Plants, seeds and oils having an elevated total monounsaturated fatty acid content

ABSTRACT

Plants, seeds and oils having a total long chain monounsaturated content of at least about 82% and an erucic acid content of at least about 15% are described. Methods for producing plants having the profiled fatty acid content are also described.

This is a divisional of application Ser. No. 09/128,602, filed Aug. 3, 1998, now U.S. Pat. No. 6,414,223.

TECHNICAL FIELD

This invention relates to fatty acid desaturases and nucleic acids encoding desaturase proteins. More particularly, the invention relates to nucleic acids encoding delta-12 and delta-15 fatty acid desaturase proteins that affect fatty acid composition in plants, polypeptides produced from such nucleic acids and plants expressing such nucleic acids.

BACKGROUND OF THE INVENTION

Many breeding studies have been conducted to improve the fatty acid profile of Brassica varieties. Pleines and Freidt, Fat Sci. Technol., 90(5), 167-171 (1988) report plant lines with reduced C_(18:3) levels (2.5-5.8%) combined with high oleic content (73-79%). Rakow and McGregor, J. Amer. Oil Chem. Soc., 50, 400-403 (Oct. 1973) discuss problems associated with selecting mutants for linoleic and linolenic acids. In Can. J. Plant Sci., 68, 509-511 (Apr. 1988) Stellar summer rape producing seed oil with 3% linolenic acid and 28% linoleic acid is disclosed. Roy and Tarr, Z. Pflanzenzuchtg, 95(3), 201-209 (1985) report transfer of genes through an interspecific cross from Brassica juncea into Brassica napus resulting in a reconstituted line combining high linoleic with low linolenic acid content. Roy and Tarr, Plant Breeding, 98, 89-96 (1987) discuss prospects for development of B. napus LL. having improved linolenic and linolenic acid content. European Patent application 323,753 published Jul. 12, 1989 discloses seeds and oils having greater than 79% oleic acid combined with less than 3.5% linolenic acid. Canvin, Can. J. Botany, 43, 63-69 (1965) discusses the effect of temperature on the fatty acid composition of oils from several seed crops including rapeseed.

Mutations typically are induced with extremely high doses of radiation and/or chemical mutagens (Gaul, H. Radiation Botany (1964) 4:155-232). High dose levels which exceed LD₅₀, and typically reach LD₉₀, led to maximum achievable mutation rates. In mutation breeding of Brassica varieties, high levels of chemical mutagens alone or combined with radiation have induced a limited number of fatty acid mutations (Rakow, G. Z. Pflanzenzuchtg (1973) 69:62-82). The low α-linolenic acid mutation derived from the Rakow mutation breeding program did not have direct commercial application because of low seed yield. The first commercial cultivar using the low α-linolenic acid mutation derived in 1973 was released in 1988 as the variety Stellar (Scarth, R. et al., Can. J. Plant Sci. (1988) 68:509-511). Stellar was 20% lower yielding than commercial cultivars at the time of its release.

Alterations in fatty acid composition of vegetable oils is desirable for meeting specific food and industrial uses. For example, Brassica canola varieties with increased monounsaturate levels (oleic acid) in the seed oil, and products derived from such oil, would improve lipid nutrition. Canola lines which are low in polyunsaturated fatty acids and high in oleic acid tend to have higher oxidative stability, which is a useful trait for the retail food industry. Useful traits of vegetable oils for industrial uses like lubrication fluids include desirable low temperature behavior such as low pour point and low cloud point along with very high oxidative stability.

Delta-12 fatty acid desaturase (also known as oleic desaturase) is involved in the enzymatic conversion of oleic acid to linoleic acid. Delta-15 fatty acid desaturase (also known as linoleic acid desaturase) is involved in the enzymatic conversion of linoleic acid to α-linolenic acid. A microsomal delta-12 desaturase has been cloned and characterized using T-DNA tagging. Okuley, et al., Plant Cell 6:147-158 (1994). The nucleotide sequences of higher plant genes encoding microsomal delta-12 fatty acid desaturase are described in Lightner et al., WO94/11516. Sequences of higher plant genes encoding microsomal and plastid delta-15 fatty acid desaturases are disclosed in Yadav, N., et al., Plant Physiol., 103:467-476 (1993), WO 93/11245 and Arondel, V. et al., Science, 258:1353-1355 (1992).

SUMMARY OF THE INVENTION

Triacylglycerols containing fatty acids with heterogenous chain lengths and with high monounsaturate levels can provide useful traits for industrial purposes. Plants with fatty acid compositions that have high monounsaturate levels and heterogenous chain lengths would provide a source of industrial oils for uses such as lubrication.

In one aspect, the invention features a Brassica plant, and progeny thereof, producing seeds having a long chain monounsaturated fatty acid content of at least about 82% and an erucic acid content of at least about 15% based on total fatty acid composition. The oleic acid and eicosenoic acid content of the seeds is at least about 37% and at least about 14%, based on total fatty acid composition, respectively. The saturated fatty acid content of such seeds is less than 7% and the polyunsaturated fatty acid content is less than about 11%.

In some embodiments, the plants have a monounsaturated fatty acid content of from about 85% to about 90% and an erucic acid content of at least about 15% based on total fatty acid composition. In such plants, the oleic acid content can be at least about 42% and in particular, from about 47% to about 56% based on total fatty acid composition. The erucic acid content is from about 17% to about 31%, and the eicosenoic acid content is from about 15% to about 21%.

The invention also features a Brassica seed oil having a long chain monounsaturated fatty acid content of at least about 82% and an erucic acid content of at least about 15% based on total fatty acid composition. Such oils can have an oleic acid and eicosenoic acid content of at least about 14% and 37%, respectively, based on total fatty acid composition. The saturated fatty acid content is less than about 7%. The polyunsaturated fatty acid content is less than about 11% and in particular embodiments, less than 9%, based on total fatty acid composition.

In some embodiments, the Brassica seed oil contains a long chain monounsaturated fatty acid content of from about 85% to about 90%. In such oils, the oleic acid content is at least about 42%, and in particular embodiments, is from about 47% to about 56%, based on total fatty acid composition. The erucic acid and eicosenoic acid content is from about 17% to about 31% and from about 15% to about 21%, respectively, based on total fatty acid composition.

The invention also features a method of producing plants having a long chain monounsaturated fatty acid content of at least about 82% and an erucic acid content of at least about 15%, based on total fatty acid composition. The methods include crossing a first plant line with a second plant line and selecting progeny with the desired fatty acid composition. The first plant line has an erucic acid content of at least about 45%. The second plant line has an oleic acid content of at least about 84%.

BRIEF DESCRIPTION OF THE SEQUENCE LISTING

SEQ ID NO:1 shows a hypothetical DNA sequence of a Brassica Fad2 gene. SEQ ID NO:2 is the deduced amino acid sequence of SEQ ID NO:1.

SEQ ID NO:3 shows a hypothetical DNA sequence of a Brassica Fad2 gene having a mutation at nucleotide 316. SEQ ID NO:4 is the deduced amino acid sequence of SEQ ID NO:3.

SEQ ID NO:5 shows a hypothetical DNA sequence of a Brassica Fad2 gene. SEQ ID NO:6 is the deduced amino acid sequence of SEQ ID NO:5.

SEQ ID NO:7 shows a hypothetical DNA sequence of a Brassica Fad2 gene having a mutation at nucleotide 515. SEQ ID NO:8 is the deduced amino acid sequence of SEQ ID NO:7.

SEQ ID NO:9 shows the DNA sequence for the coding region of a wild type Brassica Fad2-D gene. SEQ ID NO:10 is the deduced amino acid sequence for SEQ ID NO:9.

SEQ ID NO:1 shows the DNA sequence for the coding region of the IMC 129 mutant Brassica Fad2-D gene. SEQ ID NO:12 is the deduced amino acid sequence for SEQ ID NO:11.

SEQ ID NO:13 shows the DNA sequence for the coding region of a wild type Brassica Fad2-F gene. SEQ ID NO:14 is the deduced amino acid sequence for SEQ ID NO:13.

SEQ ID NO:15 shows the DNA sequence for the coding region of the Q508 mutant Brassica Fad2-F gene. SEQ ID NO:16 is the deduced amino acid sequence for SEQ ID NO:15.

SEQ ID NO:17 shows the DNA sequence for the coding region of the Q4275 mutant Brassica Fad2-F gene. SEQ ID NO:18 is the deduced amino acid sequence for SEQ ID NO:17.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 is a histogram showing the frequency distribution of seed oil oleic acid (C_(18:1)) content in a segregating population of a Q508 X Westar cross. The bar labeled WSGA 1A represents the C_(18:1) content of the Westar parent. The bar labeled Q508 represents the C_(18:1) content of the Q508 parent.

FIG. 2 shows the nucleotide sequences for a Brassica Fad2-D wild type gene (Fad2-D wt; SEQ ID NO:9), IMC 129 mutant gene (Fad2-D GA316 IMC 129; SEQ ID NO:11), Fad2-F wild type gene (Fad2-F wt; SEQ ID NO:13), Q508 mutant gene (Fad2-F TA515 Q508; SEQ ID NO:15) and Q4275 mutant gene (Fad2-F GA908 Q4275; SEQ ID NO:17).

FIG. 3 shows the deduced amino acid sequences (SEQ ID NOS:10, 12, 14, 16, and 18) for the polynucleotides of FIG. 2.

FIG. 4 is a schematic of a breeding procedure used to produce Brassica plants having a high erucic acid and a high oleic acid content.

DETAILED DESCRIPTION

All percent fatty acids herein are percent by weight of the oil of which the fatty acid is a component.

As used herein, a “line” is a group of plants that display little or no genetic variation between individuals for at least one trait. Such lines may be created by several generations of self-pollination and selection, or vegetative propagation from a single parent using tissue or cell culture techniques. As used herein, the term “variety” refers to a line which is used for commercial production.

The term “mutagenesis” refers to the use of a mutagenic agent to induce random genetic mutations within a population of individuals. The treated population, or a subsequent generation of that population, is then screened for usable trait(s) that result from the mutations. A “population” is any group of individuals that share a common gene pool. As used herein “M₀” is untreated seed. As used herein, “M₁” is the seed (and resulting plants) exposed to a mutagenic agent, while “M₂” is the progeny (seeds and plants) of self-pollinated M₁ plants, “M₃” is the progeny of self-pollinated M₂ plants, and “M₄” is the progeny of self-pollinated M₃ plants. “M₅” is the progeny of self-pollinated M₄ plants. “M₆”, “M₇”, etc. are each the progeny of self-pollinated plants of the previous generation. The term “selfed” as used herein means self-pollinated.

“Stability” or “stable” as used herein means that with respect to a given fatty acid component, the component is maintained from generation to generation for at least two generations and preferably at least three generations at substantially the same level, e.g., preferably ±5%. The method of invention is capable of creating lines with improved fatty acid compositions stable up to ±5% from generation to generation. The above stability may be affected by temperature, location, stress and time of planting. Thus, comparison of fatty acid profiles should be made from seeds produced under similar growing conditions. Stability may be measured based on knowledge of prior generation.

Intensive breeding has produced certain Brassica plants whose seed oil contains less than 2% erucic acid. The same varieties have also been bred so that the defatted meal contains less than 30 μmol glucosinolates/gram. “Canola” as used herein refers to plant seeds or oils which contain less than 2% erucic acid (C_(22:1)), and result in a defatted meal with less than 30 μmol glucosinolates/gram.

Applicants have discovered plants with mutations in a delta-12 fatty acid desaturase gene. Such plants have useful alterations in the fatty acid compositions of the seed oil. Such mutations confer, for example, an elevated oleic acid content, a decreased, stabilized linoleic acid content, or both elevated oleic acid and decreased, stabilized linoleic acid content.

Applicants have further discovered plants with mutations in a delta-15 fatty acid desaturase gene. Such plants have useful alterations in the fatty acid composition of the seed oil, e.g., a decreased, stabilized level of α-linolenic acid.

Applicants have further discovered isolated nucleic acid fragments (polynucleotides) comprising sequences that carry mutations within the coding sequence of delta-12 or delta-15 fatty acid desaturases. The mutations confer desirable alterations in fatty acid levels in the seed oil of plants carrying such mutations. Delta-12 fatty acid desaturase is also known as omega-6 fatty acid desaturase and is sometimes referred to herein as Fad2 or 12-DES. Delta-15 fatty acid desaturase is also known on omega-3 fatty acid desaturase and is sometimes referred to herein as Fad3 or 15-DES.

A nucleic acid fragment of the invention may be in the form of RNA or in the form of DNA, including cDNA, synthetic DNA or genomic DNA. The DNA may be double-stranded or single-stranded, and if single-stranded, can be either the coding strand or non-coding strand. An RNA analog may be, for example, mRNA or a combination of ribo- and deoxyribonucleotides. Illustrative examples of a nucleic acid fragment of the invention are the mutant sequences shown in FIG. 3.

A nucleic acid fragment of the invention contains a mutation in a microsomal delta-12 fatty acid desaturase coding sequence or a mutation in a microsomal delta-15 fatty acid desaturase coding sequence. Such a mutation renders the resulting desaturase gene product non-functional in plants, relative to the function of the gene product encoded by the wild-type sequence. The non-functionality of the delta-12 desaturase gene product can be inferred from the decreased level of reaction product (linoleic acid) and increased level of substrate (oleic acid) in plant tissues expressing the mutant sequence, compared to the corresponding levels in plant tissues expressing the wild-type sequence. The non-functionality of the delta-15 desaturase gene product can be inferred from the decreased level of reaction product (α-linolenic acid) and the increased level of substrate (linoleic acid) in plant tissues expressing the mutant sequence, compared to the corresponding levels in plant tissues expressing the wild-type sequence.

A nucleic acid fragment of the invention may comprise a portion of the coding sequence, e.g., at least about 10 nucleotides, provided that the fragment contains at least one mutation in the coding sequence. The length of a desired fragment depends upon the purpose for which the fragment will be used, e.g., PCR primer, site-directed mutagenesis and the like. In one embodiment, a nucleic acid fragment of the invention comprises the full length coding sequence of a mutant delta-12 or mutant delta-15 fatty acid desaturase, e.g., the mutant sequences of FIG. 3. In other embodiments, a nucleic acid fragment is about 20 to about 50 nucleotides (or base pairs, bp), or about 50 to about 500 nucleotides, or about 500 to about 1200 nucleotides in length.

Desirable alterations in fatty acid levels in the seed oil of plants can be produced using a ribozyme. Ribozyme molecules designed to cleave delta-12 or delta-15 desaturase mRNA transcripts can be used to prevent expression of delta-12 or delta-15 desaturases. While various ribozymes that cleave mRNA at site-specific recognition sequences can be used to destroy desaturase mRNAs, hammerhead ribozymes are particularly useful. Hammerhead ribozymes cleave mRNAs at locations dictated by flanking regions that form complementary base pairs with the target mRNA. The sole requirement is that the target RNA contain a 5′-UG-3′ nucleotide sequence. The construction and production of hammerhead ribozymes is well known in the art. See, for example, U.S. Pat. No. 5,254,678. Hammerhead ribozyme sequences can be embedded in a stable RNA such as a transfer RNA (tRNA) to increase cleavage efficiency in vivo. Perriman, R. et al., Proc. Natl. Acad. Sci. USA, 92(13):6175-6179 (1995); de Feyter, R. and Gaudron, J., Methods in Molecular Biology, Vol. 74, Chapter 43, “Expressing Ribozymes in Plants”, Edited by Turner, P. C, Humana Press Inc., Totowa, N.J. RNA endoribonucleases such as the one that occurs naturally in Tetrahymena thermophila, and which have been described extensively by Cech and collaborators are also useful. See, for example, U.S. Pat. No. 4,987,071.

A mutation in a nucleic acid fragment of the invention may be in any portion of the coding sequence that renders the resulting gene product non-functional. Suitable types of mutations include, without limitation, insertions of nucleotides, deletions of nucleotides, or transitions and transversions in the wild-type coding sequence. Such mutations result in insertions of one or more amino acids, deletions of one or more amino acids, and non-conservative amino acid substitutions in the corresponding gene product. In some embodiments, the sequence of a nucleic acid fragment may comprise more than one mutation or more than one type of mutation.

Insertion or deletion of amino acids in a coding sequence may, for example, disrupt the conformation of essential alpha-helical or beta-pleated sheet regions of the resulting gene product. Amino acid insertions or deletions may also disrupt binding or catalytic sites important for gene product activity. It is known in the art that the insertion or deletion of a larger number of contiguous amino acids is more likely to render the gene product non-functional, compared to a smaller number of inserted or deleted amino acids.

Non-conservative amino acid substitutions may replace an amino acid of one class with an amino acid of a different class. Non-conservative substitutions may make a substantial change in the charge or hydrophobicity of the gene product. Non-conservative amino acid substitutions may also make a substantial change in the bulk of the residue side chain, e.g., substituting an alanyl residue for a isoleucyl residue.

Examples of non-conservative substitutions include the substitution of a basic amino acid for a non-polar amino acid, or a polar amino acid for an acidic amino acid. Because there are only 20 amino acids encoded in a gene, substitutions that result in a non-functional gene product may be determined by routine experimentation, incorporating amino acids of a different class in the region of the gene product targeted for mutation.

Preferred mutations are in a region of the nucleic acid encoding an amino acid sequence motif that is conserved among delta-12 fatty acid desaturases or delta-15 fatty acid desaturases, such as a His-Xaa-Xaa-Xaa-His motif (Tables 1-3). An example of a suitable region has a conserved HECGH motif (SEQ ID NO:60) that is found, for example, in nucleotides corresponding to amino acids 105 to 109 of the Arabidopsis and Brassica delta-12 desaturase sequences, in nucleotides corresponding to amino acids 101 to 105 of the soybean delta-12 desaturase sequence and in nucleotides corresponding to amino acids 111 to 115 of the maize delta-12 desaturase sequence. See e.g., WO 94/15116; Okuley et al., Plant Cell 6:147-158 (1994). The one letter amino acid designations used herein are described in Alberts, B. et al., Molecular Biology of the Cell, 3rd edition, Garland Publishing, New York, 1994. Amino acids flanking this motif are also highly conserved among delta-12 and delta-15 desaturases and are also suitable candidates for mutations in fragments of the invention.

An illustrative embodiment of a mutation in a nucleic acid fragment of the invention is a Glu to Lys substitution in the HECGH motif (SEQ ID NO:60) of a Brassica microsomal delta-12 desaturase sequence, either the D form or the F form. This mutation results in the sequence HECGH (SEQ ID NO:60) being changed to HKCGH (SEQ ID NO:58) as seen by comparing amino acids 105-109 of SEQ ID NO:10 (wild-type D form) to amino acids 105-109 of SEQ ID NO:12 (mutant D form). A similar mutation in other Fad-2 sequences is contemplated to result in a non-functional gene product. (Compare SEQ ID NO:2 to SEQ ID NO:4).

A similar motif may be found at amino acids 101 to 105 of the Arabidopsis microsomal delta-15 fatty acid desaturase, as well as in the corresponding rape and soybean desaturases (Table 5). See, e.g., WO 93/11245; Arondel, V. et al., Science, 258:1153-1155 (1992); Yadav, N. et al., Plant Physiol., 103:467-476 (1993). Plastid delta-15 fatty acids have a similar motif (Table 5).

Among the types of mutations in an HECGH motif (SEQ ID NO:60) that render the resulting gene product non-functional are non-conservative substitutions. An illustrative example of a non-conservative substitution is substitution of a glycine residue for either the first or second histidine. Such a substitution replaces a charged residue (histidine) with a non-polar residue (glycine). Another type of mutation that renders the resulting gene product non-functional is an insertion mutation, e.g., insertion of a glycine between the cysteine and glutamic acid residues in the HECGH motif (SEQ ID NO:60).

Other regions having suitable conserved amino acid motifs include the HRRHH motif (SEQ ID NO:61) shown in Table 2, the HRTHH motif (SEQ ID NO:62) shown in Table 6 and the HVAHH motif (SEQ ID NO:63) shown in Table 3. See, e.g., WO 94/15116; Hitz, W. et al., Plant Physiol., 105:635-641 (1994); Okuley, J., et al., supra; and Yadav, N. et al., supra. An illustrative example of a mutation in the region shown in Table 3 is a mutation at nucleotides corresponding to the codon for glycine (amino acid 303 of B. napus). A non-conservative Gly to Glu substitution results in the amino acid sequence DRDYGILNKV (SEQ ID NO:47; amino acids 299-308 of SEQ ID NO:14) being changed to sequence DRDYEILNKV (SEQ ID NO:50; amino acids 299-308 of SEQ ID NO: 18) (compare wild-type F form SEQ ID NO:14 to mutant Q4275 SEQ ID NO:18, FIG. 3).

Another region suitable for a mutation in a delta-12 desaturase sequence contains the motif KYLNNP (SEQ ID NO:64) at nucleotides corresponding to amino acids 170 to 175 of the Brassica desaturase sequence. An illustrative example of a mutation is this region is a Leu to His substitution, resulting in the amino acid sequence (Table 4) KYHNNP (SEQ ID NO:53; compare wild-type Fad2-F amino acids 170-175 of SEQ ID NO:14 to mutant Fad2-F amino acids 170-175 of SEQ ID NO:16). A similar mutation in other Fad-2 amino acid sequences is contemplated to result in a non-functional gene product. (Compare SEQ ID NO:6 to SEQ ID NO:8).

TABLE 1 Alignment of Amino Acid Sequences from Microsomal Delta-12 Fatty Acid Desaturases Species Position Amino Acid Sequence Arabidopsis thaliana 100-129 IWVIAHECGH HAFSDYQWLD DTVGLIFHSF (SEQ ID NO:27) Glycine max  96-125 VWVIAHECGH HAFSKYQWVD DVVGLTLHST (SEQ ID NO:28) Zea mays 106-135 VWVIAHECGH HAFSDYSLLD DVVGLVLHSS (SEQ ID NO:29) Ricinus communis ^(a)  1-29 WVMAHDCGH HAFSDYQLLD DVVGLILHSC (SEQ ID NO:30) Brassica napus D 100-128^(b) VWVIAHECGH HAFSDYQWLD DTVGLIFHS (SEQ ID NO:65) Brassica napus F 100-128^(c) VWVIAHECGH HAFSDYQWLD DTVGLIFHS (SEQ ID NO:65) ^(a)from plasmid pRF2-1C, ^(b)positions 100-128 of SEQ ID NO:10; ^(c)positions 100-128 of SEQ ID NO:14;

TABLE 2 Alignment of Amino Acid Sequences from Microsomal Delta-12 Fatty Acid Desaturases Species Position Amino Acid Sequence Arabidopsis thaliana 130-158 LLVPYFSWKY SHRRHHSNTG SLERDEVFV (SEQ ID NO:31) Glycine max 126-154 LLVPYFSWKI SHRRHHSNTG SLERDEVFV (SEQ ID NO:32) Zea mays 136-164 LMVPYFSWKY SHRRHHSNTG SLERDEVFV (SEQ ID NO:33) Ricinus communis ^(a)  30-58 LLVPYFSWKH SHRRHHSNTG SLERDEVFV (SEQ ID NO:34) Brassica napus D 130-158^(b) LLVPYFSWKY SHRRHHSNTG SLERDEVFV (SEQ ID NO:31) Brassica napus F 130-158^(c) LLVPYFSWKY SHRRHHSNTG SLERDEVFV (SEQ ID NO:31) ^(a)from plasmid pRF2-1C; ^(b)positions 100-128 of SEQ ID NO:10; ^(c)positions 100-128 of SEQ ID NO:14;

TABLE 3 Alignment of Amino Acid Sequences from Microsomal Delta-12 Fatty Acid Desaturases Species Position Amino Acid Sequence Arabidopsis thaliana 298-333 DRDYGILNKV FHNITDTHVA HHLFSTMPHY NAMEAT (SEQ ID NO:35) Glycine max 294-329 DRDYGILNKV FHHITDTHVA HHLFSTMPHY HAMEAT (SEQ ID NO:36) Zea mays 305-340 DRDYGILNRV FHNITDTHVA HHLFSTMPHY HAMEAT (SEQ ID NO:37) Ricinus communis ^(a) 198-224 DRDYGILNKV FHNITDTQVA HHLF TMP (SEQ ID NO:38) Brassica napus D 299-334^(b) DRDYGILNKV FHNITDTHVA HHLFSTMPHY HAMEAT (SEQ ID NO:66) Brassica napus F 299-334^(c) DRDYGILNKV FHNITDTHVA HHLFSTMPHY HAMEAT (SEQ ID NO:66) ^(a)from plasmid pRF2-1C; ^(b)positions 299-334 of SEQ ID NO:10; ^(c)positions 299-334 of SEQ ID NO:14

TABLE 4 Alignment of Conserved Amino Acids from Microsomal Delta-12 Fatty Acid Desaturases Species Position Amino Acid Sequence Arabidopsis thaliana 165-180 IKWYGKYLNN PLGRIM (SEQ ID NO:39) Glycine max 161-176 VAWFSLYLNN PLGRAV (SEQ ID NO:40) Zea mays 172-187 PWYTPYVYNN PVGRVV (SEQ ID NO:41) Ricinus communis ^(a)  65-80 IRWYSKYLNN PPGRIM (SEQ ID NO:42) Brassica napus D 165-180^(b) IKWYGKYLNN PLGRTV (SEQ ID NO:67) Brassica napus F 165-180^(c) IKWYGKYLNN PLGRTV (SEQ ID NO:67) ^(a)from plasmid pRF2-1C; ^(b)positions 165-180 of SEQ ID NO:10; ^(c)positions 165-180 of SEQ ID NO:14

TABLE 5 Alignment of Conserved Amino Acids from Plastid and Microsomal Delta-15 Fatty Acid Desaturases Species Position Amino Acid Sequence Arabidopsis thaliana ^(a) 156-177 WALFVLGHD CGHGSFSNDP KLN (SEQ ID NO:43) Brassica napus ^(a) 114-135 WALFVLGHD CGHGSFSNDP RLN (SEQ ID NO:44) Glycine max ^(a) 164-185 WALFVLGHD CGHGSFSNNS KLN (SEQ ID NO:45) Arabidopsis thaliana  94-115 WAIFVLGHD CGHGSFSDIP LLN (SEQ ID NO:46) Brassica napus  87-109 WALFVLGHD CGHGSFSNDP RLN (SEQ ID NO:44) Glycine max  93-114 WALFVLGHD CGHGSFSDSP PLN (SEQ ID NO:45) ^(a)Plastid sequences

TABLE 6 Alignment of Conserved Amino Acids from Plastid and Microsomal Delta-15 Fatty Acid Desaturases Species Position Amino Acid Sequence A. thaliana ^(a) 188-216 ILVPYHGWRI SHRTHHQNHG HVENDESWH (SEQ ID NO:49) B. napus ^(a) 146-174 ILVPYHGWRI SHRTHHQNHG HVENDESWH (SEQ ID NO:49) Glycine max ^(a) 196-224 ILVPYHGWRI SHRTHHQHHG HAENDESWH (SEQ ID NO:51) A. thaliana 126-154 ILVPYHGWRI SHRTHHQNHG HVENDESNWV (SEQ ID NO:52) Brassica napus 117-145 ILVPYHGWRI SHRTHHQNHG HVENDESWV (SEQ ID NO:52) Glycine max 125-153 ILVPYHGWRI SHRTHHQNHG HIEKDESWV (SEQ ID NO:54) ^(a)Plastid sequences

The conservation of amino acid motifs and their relative positions indicates that regions of a delta-12 or delta-15 fatty acid desaturase that can be mutated in one species to generate a non-functional desaturase can be mutated in the corresponding region from other species to generate a non-functional delta-12 desaturase or delta-15 desaturase gene product in that species.

Mutations in any of the regions of Tables 1-6 are specifically included within the scope of the invention and are substantially identical to those mutations exemplified herein, provided that such mutation (or mutations) renders the resulting desaturase gene product non-functional, as discussed hereinabove.

A nucleic acid fragment containing a mutant sequence can be generated by techniques known to the skilled artisan. Such techniques include, without limitation, site-directed mutagenesis of wild-type sequences and direct synthesis using automated DNA synthesizers.

A nucleic acid fragment containing a mutant sequence can also be generated by mutagenesis of plant seeds or regenerable plant tissue by, e.g., ethyl methane sulfonate, X-rays or other mutagens. With mutagenesis, mutant plants having the desired fatty acid phenotype in seeds are identified by known techniques and a nucleic acid fragment containing the desired mutation is isolated from genomic DNA or RNA of the mutant line. The site of the specific mutation is then determined by sequencing the coding region of the delta-12 desaturase or delta-15 desaturase gene. Alternatively, labeled nucleic acid probes that are specific for desired mutational events can be used to rapidly screen a mutagenized population.

The disclosed method may be applied to all oilseed Brassica species, and to both Spring and Winter maturing types within each species. Physical mutagens, including but not limited to X-rays, UV rays, and other physical treatments which cause chromosome damage, and other chemical mutagens, including but not limited to ethidium bromide, nitrosoguanidine, diepoxybutane etc. may also be used to induce mutations. The mutagenesis treatment may also be applied to other stages of plant development, including but not limited to cell cultures, embryos, microspores and shoot apices.

“Stable mutations” as used herein are defined as M₅ or more advanced lines which maintain a selected altered fatty acid profile for a minimum of three generations, including a minimum of two generations under field conditions, and exceeding established statistical thresholds for a minimum of two generations, as determined by gas chromatographic analysis of a minimum of 10 randomly selected seeds bulked together. Alternatively, stability may be measured in the same way by comparing to subsequent generations. In subsequent generations, stability is defined as having similar fatty acid profiles in the seed as that of the prior or subsequent generation when grown under substantially similar conditions.

Mutation breeding has traditionally produced plants carrying, in addition to the trait of interest, multiple, deleterious traits, e.g., reduced plant vigor and reduced fertility. Such traits may indirectly affect fatty acid composition, producing an unstable mutation; and/or reduce yield, thereby reducing the commercial utility of the invention. To eliminate the occurrence of deleterious mutations and reduce the load of mutations carried by the plant, a low mutagen dose is used in the seed treatments to create an LD30 population. This allows for the rapid selection of single gene mutations for fatty acid traits in agronomic backgrounds which produce acceptable yields.

The seeds of several different fatty acid lines have been deposited with the American Type Culture Collection, 10801 University Blvd., Manassas, Va. 20110-2209, and have the following accession numbers.

Line Accession No. Deposit Date A129.5 40811 May 25, 1990 A133.1 40812 May 25, 1990 M3032.1 75021 Jun. 7, 1991 M3062.8 75025 Jun. 7, 1991 M3028.10 75026 Jun. 7, 1991 IMC130 75446 Apr. 16, 1993 Q4275 97569 May 10, 1996 V800655.334 V800655.126 V800654.9

In some plant species or varieties more than one form of endogenous microsomal delta-12 desaturase may be found. In amphidiploids, each form may be derived from one of the parent genomes making up the species under consideration. Plants with mutations in both forms have a fatty acid profile that differs from plants with a mutation in only one form. An example of such a plant is Brassica napus line Q508, a doubly-mutagenized line containing a mutant D-form of delta-12 desaturase (SEQ ID NO:11) and a mutant F-form of delta-12 desaturase (SEQ ID NO:15). Another example is line Q4275, which contains a mutant D-form of delta-12 desaturase (SEQ ID NO:11) and a mutant F-form of delta-12 desaturase (SEQ ID NO:17). See FIGS. 2-3.

Preferred host or recipient organisms for introduction of a nucleic acid fragment of the invention are the oil-producing species, such as soybean (Glycine max), rapeseed (e.g., Brassica napus, B. rapa and B. juncea), sunflower (Helianthus annus), castor bean (Ricinus communes), corn (Zea mays), and safflower (Carthamus tinctorius).

A nucleic acid fragment of the invention may further comprise additional nucleic acids. For example, a nucleic acid encoding a secretory or leader amino acid sequence can be linked to a mutant desaturase nucleic acid fragment such that the secretory or leader sequence is fused in-frame to the amino terminal end of a mutant delta-12 or delta-15 desaturase polypeptide. Other nucleic acid fragments are known in the art that encode amino acid sequences useful for fusing in-frame to the mutant desaturase polypeptides disclosed herein. See, e.g., U.S. Pat. No. 5,629,193 incorporated herein by reference. A nucleic acid fragment may also have one or more regulatory elements operably linked thereto.

The present invention also comprises nucleic acid fragments that selectively hybridize to mutant desaturase sequences. Such a nucleic acid fragment typically is at least 15 nucleotides in length. Hybridization typically involves Southern analysis (Southern blotting), a method by which the presence of DNA sequences in a target nucleic acid mixture are identified by hybridization to a labeled oligonucleotide or DNA fragment probe. Southern analysis typically involves electrophoretic separation of DNA digests on agarose gels, denaturation of the DNA after electrophoretic separation, and transfer of the DNA to nitrocellulose, nylon, or another suitable membrane support for analysis with a radiolabeled, biotinylated, or enzyme-labeled probe as described in sections 9.37-9.52 of Sambrook et al., (1989) Molecular Cloning, second edition, Cold Spring Harbor Laboratory, Plainview; N.Y.

A nucleic acid fragment can hybridize under moderate stringency conditions or, preferably, under high stringency conditions to a mutant desaturase sequence. High stringency conditions are used to identify nucleic acids that have a high degree of homology to the probe. High stringency conditions can include the use of low ionic strength and high temperature for washing, for example, 0.015 M NaCl/0.0015 M sodium citrate (0.1×SSC); 0.1% sodium lauryl sulfate (SDS) at 50-65° C. Alternatively, a denaturing agent such as formamide can be employed during hybridization, e.g., 50% formamide with 0.1% bovine serum albumin/0.1% Ficoll/0.1% polyvinylpyrrolidone/50 mM sodium phosphate buffer at pH 6.5 with 750 mM NaCl, 75 mM sodium citrate at 42° C. Another example is the use of 50% formamide, 5×SSC (0.75 M NaCl, 0.075 M sodium citrate), 50 mM sodium phosphate (pH 6.8), 0.1% sodium pyrophosphate, 5×Denhardt's solution, sonicated salmon sperm DNA (50 μg/ml), 0.1% SDS, and 10% dextran sulfate at 42° C., with washes at 42° C. in 0.2×SSC and 0.1% SDS.

Moderate stringency conditions refers to hybridization conditions used to identify nucleic acids that have a lower degree of identity to the probe than do nucleic acids identified under high stringency conditions. Moderate stringency conditions can include the use of higher ionic strength and/or lower temperatures for washing of the hybridization membrane, compared to the ionic strength and temperatures used for high stringency hybridization. For example, a wash solution comprising 0.060 M NaCl/0.0060 M sodium citrate (4×SSC) and 0.1% sodium lauryl sulfate (SDS) can be used at 50° C., with a last wash in 1×SSC, at 65° C. Alternatively, a hybridization wash in 1×SSC at 37° C. can be used.

Hybridization can also be done by Northern analysis (Northern blotting), a method used to identify RNAs that hybridize to a known probe such as an oligonucleotide, DNA fragment, cDNA or fragment thereof, or RNA fragment. The probe is labeled with a radioisotope such as ³²P, by biotinylation or with an enzyme. The RNA to be analyzed can be usually electrophoretically separated on an agarose or polyacrylamide gel, transferred to nitrocellulose, nylon, or other suitable membrane, and hybridized with the probe, using standard techniques well known in the art such as those described in sections 7.39-7.52 of Sambrook et al., supra.

A polypeptide of the invention comprises an isolated polypeptide having a mutant amino acid sequence, as well as derivatives and analogs thereof. See, e.g., the mutant amino acid sequences of FIG. 3. By “isolated” is meant a polypeptide that is expressed and produced in an environment other than the environment in which the polypeptide is naturally expressed and produced. For example, a plant polypeptide is isolated when expressed and produced in bacteria or fungi. A polypeptide of the invention also comprises variants of the mutant desaturase polypeptides disclosed herein, as discussed above.

In one embodiment of the claimed invention, a plant contains both a delta-12 desaturase mutation and a delta-15 desaturase mutation. Such plants can have a fatty acid composition comprising very high oleic acid and very low alpha-linolenic acid levels. Mutations in delta-12 desaturase and delta-15 desaturase may be combined in a plant by making a genetic cross between delta-12 desaturase and delta-15 desaturase single mutant lines. A plant having a mutation in delta-12 fatty acid desaturase is crossed or mated with a second plant having a mutation in delta-15 fatty acid desaturase. Seeds produced from the cross are planted and the resulting plants are selfed in order to obtain progeny seeds. These progeny seeds are then screened in order to identify those seeds carrying both mutant genes.

Alternatively, a line possessing either a delta-12 desaturase or a delta-15 desaturase mutation can be subjected to mutagenesis to generate a plant or plant line having mutations in both delta-12 desaturase and delta-15 desaturase. For example, the IMC 129 line has a mutation in the coding region (Glu₁₀₆ to Lys₁₀₆) of the D form of the microsomal delta-12 desaturase structural gene. Cells (e.g., seeds) of this line can be mutagenized to induce a mutation in a delta-15 desaturase gene, resulting in a plant or plant line carrying a mutation in a delta-12 fatty acid desaturase gene and a mutation in a delta-15 fatty acid desaturase gene.

Progeny includes descendants of a particular plant or plant line, e.g., seeds developed on an instant plant are descendants. Progeny of an instant plant include seeds formed on F₁, F₂, F₃, and subsequent generation plants, or seeds formed on BC₁, BC₂, BC₃ and subsequent generation plants.

Plants according to the invention preferably contain an altered fatty acid composition. For example, oil obtained from seeds of such plants may have from about 69 to about 90% oleic acid, based on the total fatty acid composition of the seed. Such oil preferably has from about 74 to about 90% oleic acid, more preferably from about 80 to about 90% oleic acid. In some embodiments, oil obtained from seeds produced by plants of the invention may have from about 2.0% to about 5.0% saturated fatty acids, based on total fatty acid composition of the seeds. In some embodiments, oil obtained from seeds of the invention may have from about 1.0% to about 14.0% linoleic acid, or from about 0.5% to about 10.0% α-linolenic acid.

Oil composition typically is analyzed by crushing and extracting fatty acids from bulk seed samples (e.g., 10 seeds). Fatty acid triglycerides in the seed are hydrolyzed and converted to fatty acid methyl esters. Those seeds having an altered fatty acid composition may be identified by techniques known to the skilled artisan, e.g., gas-liquid chromatography (GLC) analysis of a bulked seed sample, single seed or a single half-seed. Half-seed analysis is well known in the art to be useful because the viability of the embryo is maintained and thus those seeds having a desired fatty acid profile may be planted to form the next generation. However, half-seed analysis is also known to be an inaccurate representation of genotype of the seed being analyzed. Bulk seed analysis typically yields a more accurate representation of the fatty acid profile of a given genotype. Half-seed analysis of a population of seeds is, however, a reliable indicator of the likelihood of obtaining a desired fatty acid profile. Fatty acid composition can also be determined on larger samples, e.g., oil obtained by pilot plant or commercial scale refining, bleaching and deodorizing of endogenous oil in the seeds.

The nucleic acid fragments of the invention can be used as markers in plant genetic mapping and plant breeding programs. Such markers may include restriction fragment length polymorphism (RFLP), random amplification polymorphism detection (RAPD), polymerase chain reaction (PCR) or self-sustained sequence replication (3SR) markers, for example. Marker-assisted breeding techniques may be used to identify and follow a desired fatty acid composition during the breeding process. Marker-assisted breeding techniques may be used in addition to, or as an alternative to, other sorts of identification techniques. An example of marker-assisted breeding is the use of PCR primers that specifically amplify a sequence containing a desired mutation in delta-12 desaturase or delta-15 desaturase.

Methods according to the invention are useful in that the resulting plants and plant lines have desirable seed fatty acid compositions as well as superior agronomic properties compared to known lines having altered seed fatty acid composition. Superior agronomic characteristics include, for example, increased seed germination percentage, increased seedling vigor, increased resistance to seedling fungal diseases (damping off, root rot and the like), increased yield, and improved standability.

In another aspect, Brassica plants producing seeds having a long chain monounsaturated fatty acid content of at least about 82% and an erucic acid content of at least about 15%, based on total fatty acid composition, are featured. As used herein, “long chain” refers to carbon chains of 16 and greater, e.g., chains of 16 to 24 carbons. The long chain monounsaturated fatty acid content is distributed primarily among oleic acid, eicosenoic acid and erucic acid. The heterogenous nature of the long chain monounsaturated fatty acids in the seed oil triacylglycerols confers desirable properties to the oil.

High oleic acid lines described herein can be crossed to high erucic acid lines to produce Brassica plants having a high long chain monounsaturated fatty acid content within their seeds. Suitable high oleic acid lines are described, for example, in Example 5 and Table 17, and have an oleic acid content of about 82% to about 85%, based on total fatty acid composition. Suitable high erucic acid lines have an erucic acid content of about 45%, based on total fatty acid composition. Brassica plant line HEC01 is a high erucic acid line that is particularly useful and is sold under the trade name Hero. Other high erucic acid varieties such as Venus, Mercury, Neptune or S89-3673 have erucic acid contents of about 50% or greater and can also be used. McVetty, P. B. E. et al., Can. J. Plant Sci., 76(2):341-342 (1996); Scarth, R. et al., Can. J. Plant Sci., 75(1):205-206 (1995); and McVetty, P. B. E. et al., Can. J. Plant Sci. 76(2):343-344 (1996).

Seeds of the invention have an oleic acid and eicosenoic acid content of at least about 37% and 14%, respectively, based on total fatty acid composition. The total saturated fatty acid content is less than about 7%. As used herein, “total saturated fatty acid content” refers to the total of myristate (14:0), palmitate (16:0), stearate (18:0), arachidate (20:0), behenate (22:0) and lignocerate (24:0). The total polyunsaturated content is less than about 11% based on total fatty acid composition. As used herein, “total polyunsaturated fatty acid content” refers to the sum of linoleic (18:2), α-linolenic (18:3), and eicosadienoic (20:2) fatty acids as a percentage of the total fatty acid content.

In some embodiments, the monounsaturated content is from about 85% to about 90%. The oleic acid content within these seeds is about 42% or greater, and preferably from about 47% to about 56%. The erucic acid and eicosenoic acid content is from about 17% to about 31% and from about 15% to about 21%, respectively.

Seed oils having a long chain monounsaturated content of at least about 82% and an erucic acid content of at least about 15%, based on total fatty acid composition, are also featured. These oils can be extracted, for example, from a single line of Brassica seeds having a suitable fatty acid composition as described herein. The oleic acid and eicosenoic acid content of these oils is at least about 37% and 14%, respectively, based on total fatty acid composition. The total saturated and polyunsaturated content of these oils is less than about 7% and 11%, respectively. Preferably, the polyunsaturated content is less than about 9%. In some embodiments, the oils have a monounsaturated content of from about 85% to about 90%. The oleic acid content of these oils is at least about 42% and more preferably, from about 47% to about 56%. The oils have an erucic acid content of from about 17% to about 31% and an eicosenoic acid content of from about 15% to about 21%.

Alternatively, it is contemplated that oils of the invention can be obtained by mixing high-erucic acid rapeseed oil (HEAR) and an oil having at least about 87% oleic acid, preferably from about 90% to about 95% oleic acid, based on total fatty acid composition. HEAR oil has an erucic acid content of about 49% and an oleic acid content of about 16%.

Oils having a long chain monounsaturated content of at least about 82% unexpectedly have low temperature properties that are desirable for industrial applications such as lubrication. The basis for these properties is not known, but is it possible that the heterogeneous chain lengths of the triacylglycerols in oils of the invention impede orderly packing as the end methyl groups have a mismatch in molecular volume, reducing Van der Waals interactions. The double bond in each fatty acid moiety is present at different carbon positions along the acyl chain, which may disrupt packing and also reduce π-π electronic interactions between adjacent fatty acid chains. The high monounsaturate content is thought to provide improved oxidative stability along with high fluidity characteristics. The low levels of polyunsaturates in oils of the invention also promotes high oxidative stability, since the rates of oxidation of linoleic acid and linolenic acid at 20° C. are 12-20 times and 25 times, respectively, larger than the rate of oxidation of oleic acid.

Oxidative stability can be measured with an Oxidative Stability Index Instrument, Omnion, Inc., Rockland, Mass., according to AOCS Official Method Cd 12b-92 (revised 1993). The method is an automated replacement for the Active Oxygen Method (AOM) procedure, AOCS Official Method Cd 12-57. Oxidative stability of oils having a long chain monounsaturated content of at least about 82% is from about 40 AOM hours to about 100 AOM hours in the absence of added antioxidants. In comparison, mid-oleic canola oil (about 76% oleic acid) and high erucic acid rapeseed oil have oxidative stabilities of about 38 and 16 AOM hours, respectively, in the absence of added antioxidants.

The oils of the invention have desirable functional properties, e.g., low temperature behavior and a high viscosity index, along with high oxidative stability. The presence of higher molecular weight fatty acids increases the molecular weight of the triacylglycerols, providing the oil with a higher flash point and a higher fire point. The increased molecular weight also improves the viscosity index of the oils. Viscosity index is an arbitrary number that indicates the viscosity change with temperature of a lubricant. The Dean and Davis viscosity index can be calculated from observed viscosities of a lubricant at 40° C. and 100° C. and can produce values ranging from 0 to values greater than 200. A higher viscosity index value indicates that the viscosity of the oil changes less with a change in temperature. In other words, the higher the viscosity index, the smaller the difference in viscosity between high and low temperatures.

An oil of the invention can be formulated for industrial applications such as engine lubricants or as hydraulic fluids by addition of one or more additives to an oil having a long chain monounsaturated fatty acid content of at least about 82% and an erucic acid content of at least about 15%, based on total fatty acid composition. For example, a transmission fluid for diesel engines can be made that includes antioxidants, anti-foam additives, anti-wear additives, corrosion inhibitors, dispersants, detergents, and acid neutralizers, or combinations thereof. Hydraulic oil compositions can include antioxidants, anti-rust additives, anti-wear additives, pour point depressants, viscosity-index improvers and anti-foam additives or combinations thereof. Specific formulations will vary depending on the end use of the oil; suitability of a formulation for a specific end use can be assessed using standard techniques.

Typical antioxidants include zinc dithiophosphates, methyl dithiocarbamates, hindered phenols, phenol sulfides, metal phenol sulfides, metal salicylates, aromatic amines, phospho-sulfurized fats and olefins, sulfurized olefins, sulfurized fats and fat derivatives, sulfurized paraffins, sulfurized carboxylic acids, disalieylal-1,2,-propane diamine, 2,4-bis (alkyldithio-1,3,4-thiadiazoles) and dilauryl selenide. Antioxidants are typically present in amounts from about 0.01% to about 5%, based on the weight of the composition. In particular, about 0.01% to about 1.0% of antioxidant is added to an oil of the invention. See U.S. Pat. No. 5,451,334 for additional antioxidants.

Rust inhibitors protect surfaces against rust and include, for example, alkylsuccinic type organic acids, and derivatives thereof, alkylthioacetic acids and derivatives thereof, organic amines, organic phosphates, polyhyndric alcohols and sodium and calcium sulphonates. Anti-wear additives adsorb on metal and provide a film that reduces metal-to-metal contact. In general, anti-wear additives include zinc dialkyldithiophosphates, tricresyl phosphate, didodecyl phosphite, sulfurized sperm oil, sulfurized terpenes and zinc dialkyldithiocarbamate, and are used in amounts from about 0.05% to about 4.5%.

Corrosion inhibitors include dithiophosphates and in particular, zinc dithiophosphates, metal sulfonates, metal phenate sulfides, fatty acids, acid phosphate esters and alkyl succinic acids.

Pour point depressants permit flow of the oil composition below the pour point of the unmodified lubricant. Common pour point depressants include polymethacrylates, wax alkylated naphthalene polymers, wax alkylated phenol polymers and chlorinated polymers and are typically present in amounts of about 1% or less. See, for example, U.S. Pat. Nos. 5,451,334 and 5,413,725. The viscosity-index can be increased by adding polyisobutylenes, polymethacrylates, polyacrylates, ethylene propylene copolymers, styrene isoprene copolymers, styrene butadiene copolymers and styrene maleic ester copolymers.

Anti-foam additives reduce or prevent the formation of a stable surface foam and are typically present in amounts from about 0.00003% to about 0.05%. Polymethylsiloxanes, polymethacrylates, salts of alkyl alkylene dithiophosphates, amyl acrylate telomer and poly(2-ethylhexylacrylate-co-ethyl acrylate are non-limiting examples of anti-foam additives.

Detergents and dispersants are polar materials that provide a cleaning function. Detergents include metal sulfonates, metal salicylates and metal thiophosponates. Dispersants include polyamine succinimides, hydroxy benzyl polyamines, polyamine succinamides, polyhydroxy succinic esters and polyamine amide imidazolines.

While the invention is susceptible to various modifications and alternative forms, certain specific embodiments thereof are described in the general methods and examples set forth below. For example the invention may be applied to all Brassica species, including B. rapa, B. juncea, and B. hirta, to produce substantially similar results. It should be understood, however, that these examples are not intended to limit the invention to the particular forms disclosed but, instead the invention is to cover all modifications, equivalents and alternatives falling within the scope of the invention. This includes the use of somaclonal variation; physical or chemical mutagenesis of plant parts; anther, microspore or ovary culture followed by chromosome doubling; or self- or cross-pollination to transmit the fatty acid trait, alone or in combination with other traits, to develop new Brassica lines.

EXAMPLE 1 Mutagenesis

Seeds of Westar, a Canadian (Brassica napus) spring canola variety, were subjected to chemical mutagenesis. Westar is a registered Canadian spring variety with canola quality. The fatty acid composition of field-grown Westar, 3.9% C_(16:0), 1.9% C_(18:0), 67.5% C_(18:1), 17.6% C_(18:2), 7.4% C_(18:3), <2% C20:1+C_(22:1), has remain stable under commercial production, with <±10% deviation, since 1982.

Prior to mutagenesis, 30,000 seeds of B. napus cv. Westar seeds were preimbibed in 300-seed lots for two hours on wet filter paper to soften the seed coat. The preimbibed seeds were placed in 80 mM ethylmethanesulfonate (EMS) for four hours. Following mutagenesis, the seeds were rinsed three times in distilled water. The seeds were sown in 48-well flats containing Pro-Mix. Sixty-eight percent of the mutagenized seed germinated. The plants were maintained at 25° C./15° C., 14/10 hr day/night conditions in the greenhouse. At flowering, each plant was individually self-pollinated.

M₂ seed from individual plants were individually catalogued and stored, approximately 15,000 M₂ lines was planted in a summer nursery in Carman, Manitoba. The seed from each selfed plant were planted in 3-meter rows with 6-inch row spacing. Westar was planted as the check variety. Selected lines in the field were selfed by bagging the main raceme of each plant. At maturity, the selfed plants were individually harvested and seeds were catalogued and stored to ensure that the source of the seed was known.

Self-pollinated M₃ seed and Westar controls were analyzed in 10-seed bulk samples for fatty acid composition via gas chromatography. Statistical thresholds for each fatty acid component were established using a Z-distribution with a stringency level of 1 in 10,000. Mean and standard deviation values were determined from the non-mutagenized Westar control population in the field. The upper and lower statistical thresholds for each fatty acid were determined from the mean value of the population±the standard deviation, multiplied by the Z-distribution. Based on a population size of 10,000, the confidence interval is 99.99%.

The selected M₃ seeds were planted in the greenhouse along with Westar controls. The seed was sown in 4-inch pots containing Pro-Mix soil and the plants were maintained at 25° C./15° C., 14/10 hr day/night cycle in the greenhouse. At flowering, the terminal raceme was self-pollinated by bagging. At maturity, selfed M₄ seed was individually harvested from each plant, labelled, and stored to ensure that the source of the seed was known.

The M₄ seed was analyzed in 10-seed bulk samples. Statistical thresholds for each fatty acid component were established from 259 control samples using a Z-distribution of 1 in 800. Selected M₄ lines were planted in a field trial in Carman, Manitoba in 3-meter rows with 6-inch spacing. Ten M₄ plants in each row were bagged for self-pollination. At maturity, the selfed plants were individually harvested and the open pollinated plants in the row were bulk harvested. The M₅ seed from single plant selections was analyzed in 10-seed bulk samples and the bulk row harvest in 50-seed bulk samples.

Selected M₅ lines were planted in the greenhouse along with Westar controls. The seed was grown as previously described. At flowering the terminal raceme was self-pollinated by bagging. At maturity, selfed M₆ seed was individually harvested from each plant and analyzed in 10-seed bulk samples for fatty acid composition.

Selected M₆ lines were entered into field trials in Eastern Idaho. The four trial locations were selected for the wide variability in growing conditions. The locations included Burley, Tetonia, Lamont and Shelley (Table 7). The lines were planted in four 3-meter rows with an 8-inch spacing, each plot was replicated four times. The planting design was determined using a Randomized Complete Block Design. The commercial cultivar Westar was used as a check cultivar. At maturity the plots were harvested to determine yield. Yield of the entries in the trial was determined by taking the statistical average of the four replications. The Least Significant Difference Test was used to rank the entries in the randomized complete block design.

TABLE 7 Trial Locations for Selected Fatty Acid Mutants LOCATION SITE CHARACTERIZATIONS BURLEY Irrigated. Long season. High temperatures during flowering. TETONIA Dryland. Short season. Cool temperatures. LAMONT Dryland. Short season. Cool temperatures. SHELLEY Irrigated. Medium season. High temperatures during flowering.

To determine the fatty acid profile of entries, plants in each plot were bagged for self-pollination. The M₇ seed from single plants was analyzed for fatty acids in ten-seed bulk samples.

To determine the genetic relationships of the selected fatty acid mutants crosses were made. Flowers of M₆ or later generation mutations were used in crossing. F₁ seed was harvested and analyzed for fatty acid composition to determine the mode of gene action. The F₁ progeny were planted in the greenhouse. The resulting plants were self-pollinated, the F₂ seed harvested and analyzed for fatty acid composition for allelism studies. The F₂ seed and parent line seed was planted in the greenhouse, individual plants were self-pollinated. The F₃ seed of individual plants was tested for fatty acid composition using 10-seed bulk samples as described previously.

In the analysis of some genetic relationships dihaploid populations were made from the microspores of the F₁ hybrids. Self-pollinated seed from dihaploid plants were analyzed for fatty acid analysis using methods described previously.

For chemical analysis, 10-seed bulk samples were hand ground with a glass rod in a 15-mL polypropylene tube and extracted in 1.2 mL 0.25 N KOH in 1:1 ether/methanol. The sample was vortexed for 30 sec. and heated for 60 sec. in a 60° C. water bath. Four mL of saturated NaCl and 2.4 mL of iso-octane were added, and the mixture was vortexed again. After phase separation, 600 μL of the upper organic phase were pipetted into individual vials and stored under nitrogen at −5° C. One μL samples were injected into a Supelco SP-2330 fused silica capillary column (0.25 mm ID, 30 M length, 0.20 μm df).

The gas chromatograph was set at 180° C. for 5.5 minutes, then programmed for a 2° C./minute increase to 212° C., and held at this temperature for 1.5 minutes. Total run time was 23 minutes. Chromatography settings were: Column head pressure—15 psi, Column flow (He)—0.7 mL/min., Auxiliary and Column flow—33 μL/min., Hydrogen flow—33 μL/min., Air flow—400 μL/min., Injector temperature—250° C., Detector temperature—300° C., Split vent—1/15.

Table 8 describes the upper and lower statistical thresholds for each fatty acid of interest.

TABLE 8 Statistical Thresholds for Specific Fatty Acids Derived from Control Westar Plantings Percent Fatty Acids Genotype C_(16:0) C_(18.0) C_(18:1) C_(18:2) C_(18:3) Sats* M₃ Generation(1 in 10,000 rejection rate) Lower 3.3 1.4 — 13.2 5.3 6.0 Upper 4.3 2.5 71.0 21.6 9.9 8.3 M₄ Generation(1 in 800 rejection rate) Lower 3.6 0.8 — 12.2 3.2 5.3 Upper 6.3 3.1 76.0 32.4 9.9 11.2 M₅ Generation (1 in 755 rejection rate) Lower 2.7 0.9 — 9.6 2.6 4.5 Upper 5.7 2.7 80.3 26.7 9.6 10.0 *Sats = Total Saturate Content

EXAMPLE 2 High Oleic Acid Canola Lines

In the studies of Example 1, at the M₃ generation, 31 lines exceeded the upper statistical threshold for oleic acid (≧71.0%). Line W7608.3 had 71.2% oleic acid. At the M₄ generation, its selfed progeny (W7608.3.5, since designated A129.5) continued to exceed the upper statistical threshold for C_(18:1) with 78.8% oleic acid. M₁ seed of five self-pollinated plants of line A129.5 (ATCC 40811) averaged 75.0% oleic acid. A single plant selection, A129.5.3 had 75.6% oleic acid. The fatty acid composition of this high oleic acid mutant, which was stable under both field and greenhouse conditions to the M₇ generation, is summarized in Table 9. This line also stably maintained its mutant fatty acid composition to the M₇ generation in field trials in multiple locations. Over all locations the self-pollinated plants (A129) averaged 78.3% oleic acid. The fatty acid composition of the A129 for each Idaho trial location are summarized in Table 10. In multiple location replicated yield trials, A129 was not significantly different in yield from the parent cultivar Westar.

The canola oil of A129, after commercial processing, was found to have superior oxidative stability compared to Westar when measured by the Accelerated Oxygen Method (AOM), American Oil Chemists' Society Official Method Cd 12-57 for fat stability; Active Oxygen Method (revised 1989). The AOM of Westar was 18 AOM hours and for A129 was 30 AOM hours.

TABLE 9 Fatty Acid Composition of a High Oleic Acid Canola Line Produced by Seed Mutagenesis Percent Fatty Acids Genotype C_(16:0) C_(18:0) C_(18:1) C_(18:2) C_(18:3) Sats Westar 3.9 1.9 67.5 17.6 7.4 7.0 W7608.3 3.9 2.4 71.2 12.7 6.1 7.6 (M₃) W7608.3.5 3.9 2.0 78.8 7.7 3.9 7.3 (M₄) A129.5.3 3.8 2.3 75.6 9.5 4.9 7.6 (M₅) Sats = Total Saturate Content

TABLE 10 Fatty Acid Composition of a Mutant High Oleic Acid Line at Different Field Locations in Idaho Percent Fatty Acids Location C_(16:0) C_(18:0) C_(18:1) C_(18:2) C_(18:3) Sats Burley 3.3 2.1 77.5 8.1 6.0 6.5 Tetonia 3.5 3.4 77.8 6.5 4.7 8.5 Lamont 3.4 1.9 77.8 7.4 6.5 6.3 Shelley 3.3 2.6 80.0 5.7 4.5 7.7 Sats = Total Saturate Content

The genetic relationship of the high oleic acid mutation A129 to other oleic desaturases was demonstrated in crosses made to commercial canola cultivars and a low linolenic acid mutation. A129 was crossed to the commercial cultivar Global (C_(16:0)—4.5%, C_(18:0)—1.5%, C_(18:1)—62.9%, C_(18:2)—20.0%, C_(18:3)—7.3%). Approximately 200 F₂ individuals were analyzed for fatty acid composition. The results are summarized in Table 11. The segregation fit 1:2:1 ratio suggesting a single co-dominant gene controlled the inheritance of the high oleic acid phenotype.

TABLE 11 Genetic Studies of A129 X Global Frequency Genotype C_(18:1) Content(%) Observed Expected od−od− 77.3  43 47 od−od+ 71.7 106 94 od+od+ 66.1  49 47

A cross between A129 and IMC 01, a low linolenic acid variety (C_(16:0)—4.1%, C_(18:0)—1.9%, C_(18:1)—66.4%, C_(18:2)—18.1%, C_(18:3)—5.7%), was made to determine the inheritance of the oleic acid desaturase and linoleic acid desaturase. In the F₁ hybrids both the oleic acid and linoleic acid desaturase genes approached the mid-parent values indicating a co-dominant gene actions. Fatty acid analysis of the F₂ individuals confirmed a 1:2:1:2:4:2:1:2:1 segregation of two independent, co-dominant genes (Table 12). A line was selected from the cross of A129 and IMC01 and designated as IMC130 (ATCC deposit no. 75446) as described in U.S. patent application Ser. No. 08/425,108, incorporated herein by reference.

TABLE 12 Genetic Studies of A129 X IMC 01 Frequency Genotype Ratio Observed Expected od−od−ld−ld− 1 11 12 od−od−ld−ld+ 2 30 24 od−od−ld+ld+ 1 10 12 od−od+ld−ld− 2 25 24 od−od+ld−ld+ 4 54 47 od−od+ld+ld+ 2 18 24 od+od+ld−ld− 1  7 12 od+od+ld−ld+ 2 25 24 od+od+ld+ld+ 1  8 12

An additional high oleic acid line, designated A128.3, was also produced by the disclosed method. A 50-seed bulk analysis of this line showed the following fatty acid composition: C_(16:0)—3.5%, C_(18:0)—1.8%, C_(18:1)—77.3%, C_(18:2)—9.0%, C_(18:3)—5.6%, FDA Sats—5.3%, Total Sats—6.4%. This line also stably maintained its mutant fatty acid composition to the M₇ generation. In multiple locations replicated yield trials, A128 was not significantly different in yield from the parent cultivar Westar.

A129 was crossed to A128.3 for allelism studies. Fatty acid composition of the F₂ seed showed the two lines to be allelic. The mutational events in A129 and A128.3 although different in origin were in the same gene.

An additional high oleic acid line, designated M3028.-10 (ATCC 75026), was also produced by the disclosed method in Example 1. A 10-seed bulk analysis of this line showed the following fatty acid composition: C_(16:0)—3.5%, C_(18:0)—1.8%, C_(18:1)—77.3%, C_(18:2)—9.0%, C_(18:3)—5.6%, FDA Saturates—5.3%, Total Saturates—6.4%. In a single location replicated yield trial M3028.10 was not significantly different in yield from the parent cultivar Westar.

EXAMPLE 3 Low Linoleic Acid Canola

In the studies of Example 1, at the M₃ generation, 80 lines exceeded the lower statistical threshold for linoleic acid (≦13.2%). Line W12638.8 had 9.4% linoleic acid. At the M₄ and M₅ generations, its selfed progenies [W12638.8, since designated A133.1 (ATCC 40812)] continued to exceed the statistical threshold for low C_(18:2) with linoleic acid levels of 10.2% and 8.4%, respectively. The fatty acid composition of this low linoleic acid mutant, which was stable to the M₇ generation under both field and greenhouse conditions, is summarized in Table 13. In multiple location replicated yield trials, A133 was not significantly different in yield from the parent cultivar Westar. An additional low linoleic acid line, designated M3062.8 (ATCC 75025), was also produced by the disclosed method. A 10-seed bulk analysis of this line showed the following fatty acid composition: C_(16:0)—3.8%, C_(18:0)—2.3%, C_(18:1)—77.1%, C_(18:2)—8.9%, C_(18:3)—4.3%, FDA Sats—6.1%. This line has also stably maintained its mutant fatty acid composition in the field and greenhouse.

TABLE 13 Fatty Acid Composition of a Low Linoleic Acid Canola Line Produced by Seed Mutagenesis Percent Fatty Acids Genotype C_(16:0) C_(18:0) C_(18:1) C_(18:2) C_(18:3) Sats^(b) Westar 3.9 1.9 67.5 17.6 7.4 7.0 W12638.8 3.9 2.3 75.0 9.4 6.1 7.5 (M₃) W12638.8.1 4.1 1.7 74.6 10.2 5.9 7.1 (M₄) A133.1.8 3.8 2.0 77.7 8.4 5.0 7.0 (M₅) ^(a)Letter and numbers up to second decimal point indicate the plant line. Number after second decimal point indicates an individual plant. ^(b)Sats = Total Saturate Content

EXAMPLE 4 Low Linolenic and Linoleic Acid Canola

In the studies of Example 1, at the M₃ generation, 57 lines exceeded the lower statistical threshold for linolenic acid (≦5.3%). Line W14749.8 had 5.3% linolenic acid and 15.0% linoleic acid. At the M₄ and M₅ generations, its selfed progenies [W14749.8, since designated M3032 (ATCC 75021)] continued to exceed the statistical threshold for low C_(18:3) with linolenic acid levels of 2.7% and 2.3%, respectively, and for a low sum of linolenic and linoleic acids with totals of 11.8% and 12.5% respectively. The fatty acid composition of this low linolenic acid plus linoleic acid mutant, which was stable to the M₅ generation under both field and greenhouse conditions, is summarized in Table 14. In a single location replicated yield trial M3032 was not significantly different in yield from the parent cultivar (Westar).

TABLE 14 Fatty Acid Composition of a Low Linolenic Acid Canola Line Produced by Seed Mutagenesis Percent Fatty Acids Genotype C_(16:0) C_(18:0) C_(18:1) C_(18:2) C_(18:3) Sats Westar 3.9 1.9 67.5 17.6 7.4 7.0 W14749.8 4.0 2.5 69.4 15.0 5.3 6.5 (M₃) M3032.8 3.9 2.4 77.9 9.1 2.7 6.4 (M₄) M3032.1 3.5 2.8 80.0 10.2 2.3 6.5 (M₅) Sats = Total Saturate Content

EXAMPLE 5 Canola Lines Q508 and 04275

Seeds of the B. napus line IMC-129 were mutagenized with methyl N-nitrosoguanidine (MNNG). The MNNG treatment consisted of three parts: pre-soak, mutagen application, and wash. A 0.05M Sorenson's phosphate buffer was used to maintain pre-soak and mutagen treatment pH at 6.1. Two hundred seeds were treated at one time on filter paper (Whatman #3M) in a petri dish (100 mm×15 mm). The seeds were pre-soaked in 15 mls of 0.05 M Sorenson's buffer, pH 6.1, under continued agitation for two hours. At the end of the pre-soak period, the buffer was removed from the plate.

A 10 mM concentration of MNNG in 0.05 M Sorenson's buffer, pH 6.1, was prepared prior to use. Fifteen ml of 10 m MNNG was added to the seeds in each plate. The seeds were incubated at 22° C.±3° C. in the dark under constant agitation for four (4) hours. At the end of the incubation period, the mutagen solution was removed.

The seeds were washed with three changes of distilled water at 10 minute intervals. The fourth wash was for thirty minutes. This treatment regime produced an LD60 population.

Treated seeds were planted in standard greenhouse potting soil and placed into an environmentally controlled greenhouse. The plants were grown under sixteen hours of light. At flowering, the racemes were bagged to produce selfed seed. At maturity, the M2 seed was harvested. Each M2 line was given an identifying number. The entire MNNG-treated seed population was designated as the Q series.

Harvested M2 seeds was planted in the greenhouse. The growth conditions were maintained as previously described. The racemes were bagged at flowering for selfing. At maturity, the selfed M3 seed was harvested and analyzed for fatty acid composition. For each M3 seed line, approximately 10-15 seeds were analyzed in bulk as described in Example 1.

High oleic-low linoleic M3 lines were selected from the M3 population using a cutoff of >82% oleic acid and <5.0% linoleic. From the first 1600 M3 lines screened for fatty acid composition, Q508 was identified. The Q508 M3 generation was advanced to the M4 generation in the greenhouse. Table 15 shows the fatty acid composition of Q508 and IMC 129. The M4 selfed seed maintained the selected high oleic-low linoleic acid phenotype (Table 16).

TABLE 15 Fatty Acid Composition of A129 and High Oleic Acid M3 Mutant Q508 Line # 16:0 18:0 18:1 18:2 18:3 A129* 4.0 2.4 77.7 7.8 4.2 Q508 3.9 2.1 84.9 2.4 2.9 *Fatty acid composition of A129 is the average of 50 self-pollinated plants grown with the M3 population

M₄ generation Q508 plants had poor agronomic qualities in the field compared to Westar. Typical plants were slow growing relative to Westar, lacked early vegetative vigor, were short in stature, tended to be chlorotic and had short pods. The yield of Q508 was very low compared to Westar.

The M₄ generation Q508 plants in the greenhouse tended to be reduced in vigor compared to Westar. However, Q508 yields in the greenhouse were greater than Q508 yields in the field.

TABLE 16 Fatty Acid Composition of Seed Oil from Greenhouse-Grown Q508, IMC 129 and Westar. FDA Line 16:0 18:0 18:1 18:2 18:3 Sats IMC 129^(a) 4.0 2.4 77.7 7.8 4.2 6.4 Westar^(b) 3.9 1.9 67.5 17.6 7.4 >5.8 Q508^(c) 3.9 2.1 84.9 2.4 2.9 6.0 ^(a)Average of 50 self-pollinated plants ^(b)Data from Example 1 ^(c)Average of 50 self-pollinated plants

Nine other M4 high-oleic low-linoleic lines were also identified: Q3603, Q3733, Q4249, Q6284, Q6601, Q6761, Q7415, Q4275, and Q6676. Some of these lines had good agronomic characteristics and an elevated oleic acid level in seeds of about 80% to about 84%.

Q4275 was crossed to the variety Cyclone. After selfing for seven generations, mature seed was harvested from 93GS34-179, a progeny line of the Q4275xCyclone cross. Referring to Table 17, fatty acid composition of a bulk seed sample shows that 93GS34 retained the seed fatty acid composition of Q4275. 93GS34-179 also maintained agronomically desirable characteristics.

After more than seven generations of selfing of Q4275, plants of Q4275, IMC 129 and 93GS34 were field grown during the summer season. The selections were tested in 4 replicated plots (5 feet×20 feet) in a randomized block design. Plants were open pollinated. No selfed seed was produced. Each plot was harvested at maturity, and a sample of the bulk harvested seed from each line was analyzed for fatty acid composition as described above. The fatty acid compositions of the selected lines are shown in Table 17.

TABLE 17 Fatty Acid Composition of Field Grown IMC 129, Q4275 and 93GS34 Seeds Fatty Acid Composition (%) Line C_(16:0) C_(18:0) C_(18:1) C_(18:2) C_(18.3) FDA Sats IMC 129 3.3 2.4 76.7 8.7 5.2 5.7 Q4275 3.7 3.1 82.1 4.0 3.5 6.8 93GS34−179 2.6 2.7 85.0 2.8 3.3 5.3

The results shown in Table 17 show that Q4275 maintained the selected high oleic—low linoleic acid phenotype under field conditions. The agronomic characteristics of Q4275 plants were superior to those of Q508.

M₄ generation Q508 plants were crossed to a dihaploid selection of Westar, with Westar serving as the female parent. The resulting F1 seed was termed the 92EF population. About 126 F1 individuals that appeared to have better agronomic characteristics than the Q508 parent were selected for selfing. A portion of the F₂ seed from such individuals was replanted in the field. Each F2 plant was selfed and a portion of the resulting F3 seed was analyzed for fatty acid composition. The content of oleic acid in F₃ seed ranged from 59 to 79%. No high oleic (>80%) individuals were recovered with good agronomic type.

A portion of the F₂ seed of the 92EF population was planted in the greenhouse to analyze the genetics of the Q508 line. F₃ seed was analyzed from 380 F2 individuals. The C_(18:1) levels of F₃ seed from the greenhouse experiment is depicted in FIG. 1. The data were tested against the hypothesis that Q508 contains two mutant genes that are semi-dominant and additive: the original IMC 129 mutation as well as one additional mutation. The hypothesis also assumes that homozygous Q508 has greater than 85% oleic acid and homozygous Westar has 62-67% oleic acid. The possible genotypes at each gene in a cross of Q508 by Westar may be designated as:

AA=Westar Fad2^(a)

BB=Westar Fad2^(b)

 aa=Q508 Fad2^(a)

bb=Q508 Fad2^(b)

Assuming independent segregation, a 1:4:6:4:1 ratio of phenotypes is expected. The phenotypes of heterozygous plants are assumed to be indistinguishable and, thus, the data were tested for fit to a 1:14:1 ratio of homozygous Westar: heterozygous plants: homozygous Q508.

Phenotypic # of Ratio Westar Alleles Genotype 1 4 AABB(Westar) 4 3 AABb, AaBB, AABb, AaBB 6 2 AaBb, AAbb, AaBb, AaBb, aaBB, AaBb 4 1 Aabb, aaBb, Aabb, aaBb 1 0 aabb (Q508)

Using Chi-square analysis, the oleic acid data fit a 1:14:1 ratio. It was concluded that Q508 differs from Westar by two major genes that are semi-dominant and additive and that segregate independently. By comparison, the genotype of IMC 129 is

The fatty acid composition of representative F3 individuals having greater than 85% oleic acid in seed oil is shown in Table 18. The levels of saturated fatty acids are seen to be decreased in such plants, compared to Westar.

TABLE 18 92EF F₃ Individuals with >85% C_(18:1) in Seed Oil F3 Plant Fatty Acid Composition (%) Identifier C16:0 C18:0 C18:1 C18:2 C18:3 FDASA +38068 3.401 1.582 85.452 2.134 3.615 4.983 +38156 3.388 1.379 85.434 2.143 3.701 4.767 +38171 3.588 1.511 85.289 2.367 3.425 5.099 +38181 3.75  1.16  85.312 2.968 3.819 4.977 +38182 3.529 0.985 85.905 2.614 3.926 4.56  +38191 3.364 1.039 85.737 2.869 4.039 4.459 +38196 3.557 1.182 85.054 2.962 4.252 4.739 +38202 3.554 1.105 86.091 2.651 3.721 4.713 +38220 3.093 1.16  86.421 1.931 3.514 4.314 +38236 3.308 1.349 85.425 2.37  3.605 4.718 +38408 3.617 1.607 85.34  2.33  3.562 5.224 +38427 3.494 1.454 85.924 2.206 3.289 4.948 +38533 3.64  1.319 85.962 2.715 3.516 4.959

EXAMPLE 6 Leaf and Root Fatty Acid Profiles of Canola Lines IMC-129 0508. and Westar

Plants of Q508, IMC 129 and Westar were grown in the greenhouse. Mature leaves, primary expanding leaves, petioles and roots were harvested at the 6-8 leaf stage, frozen in liquid nitrogen and stored at −70° C. Lipid extracts were analyzed by GLC as described in Example 1. The fatty acid profile data are shown in Table 19. The data in Table 19 indicate that total leaf lipids in Q508 are higher in C_(18:1) content than the C_(18:2) plus C_(18:3) content. The reverse is true for Westar and IMC 129. The difference in total leaf lipids between Q508 and IMC 129 is consistent with the hypothesis that a second Fad2 gene is mutated in Q508.

The C_(16:3) content in the total lipid fraction was about the same for all three lines, suggesting that the plastid FadC gene product was not affected by the Q508 mutations. To confirm that the FadC gene was not mutated, chloroplast lipids were separated and analyzed. No changes in chloroplast C_(16:1), C_(16:2) or C_(16:3) fatty acids were detected in the three lines. The similarity in plastid leaf lipids among Q508, Westar and IMC 129 is consistent with the hypothesis that the second mutation in Q508 affects a microsomal Fad2 gene and not a plastid FadC gene.

TABLE 19 MATURE EXPANDING LEAF LEAF PETIOLE ROOT West. 129 3Q508 West. 129 3Q508 West. 129 3Q508 West. 129 3Q508 16:0 12.1 11.9 10.1 16.4 16.1 11.3 21.7 23.5 11.9 21.1 21.9 12.0 16:1 0.8 0.6 1.1 0.7 0.6 1.1 1.0 1.3 1.4 — — — 16:2 2.3 2.2 2.0 2.8 3.1 2.8 1.8 2.2 1.8 — — — 16:3 14.7 15.0 14.0 6.3 5.4 6.9 5.7 4.6 5.7 — — — 18:0 2.2 1.6 1.2 2.5 2.8 1.5 3.7 4.0 1.6   3.6  2.9  2.5 18:1 2.8 4.9 16.7 3.8 8.3 38.0 4.9 12.9 46.9   3.5  6.1  68.8 18:2 12.6 11.5 6.8 13.3 13.8 4.9 20.7 18.3 5.2 28.0 30.4 4.4 18:3 50.6 50.3 46.0 54.2 50.0 33.5 40.4 33.2 25.3 43.8 38.7 12.3

EXAMPLE 7 Sequences of Mutant and Wild-Type Delta-12 Fatty Acid Desaturases from B. napus

Primers specific for the FAD2 structural gene were used to clone the entire open reading frame (ORF) of the D and F delta-12 desaturase genes by reverse transcriptase polymerase chain reaction (RT-PCR). RNA from seeds of IMC 129, Q508 and Westar plants was isolated by standard methods and was used as template. The RT-amplified fragments were used for nucleotide sequence determination. The DNA sequence of each gene from each line was determined from both strands by standard dideoxy sequencing methods.

Sequence analysis revealed a G to A transversion at nucleotide 316 (from the translation initiation codon) of the D gene in both IMC 129 and Q508, compared to the sequence of Westar. The transversion changes the codon at this position from GAG to AAG and results in a non-conservative substitution of glutamic acid, an acidic residue, for lysine a basic residue. The presence of the same mutation in both lines was expected since the Q508 line was derived from IMC 129. The same base change was also detected in Q508 and IMC 129 when RNA from leaf tissue was used as template.

The G to A mutation at nucleotide 316 was confirmed by sequencing several independent clones containing fragments amplified directly from genomic DNA of IMC 129 and Westar. These results eliminated the possibility of a rare mutation introduced during reverse transcription and PCR in the RT-PCR protocol. It was concluded that the IMC 129 mutant is due to a single base transversion at nucleotide 316 in the coding region of the D gene of rapeseed microsomal delta 12-desaturase.

A single base transition from T to A at nucleotide 515 of the F gene was detected in Q508 compared to the Westar sequence. The mutation changes the codon at this position from CTC to CAC, resulting in the non-conservative substitution of a non-polar residue, leucine, for a polar residue, histidine, in the resulting gene product. No mutations were found in the F gene sequence of IMC 129 compared to the F gene sequence of Westar.

These data support the conclusion that a mutation in a delta-12 desaturase gene sequence results in alterations in the fatty acid profile of plants containing such a mutated gene. Moreover, the data show that when a plant line or species contains two delta-12 desaturase loci, the fatty acid profile of an individual having two mutated loci differs from the fatty acid profile of an individual having one mutated locus.

The mutation in the D gene of IMC 129 and Q508 mapped to a region having a conserved amino acid motif (His-Xaa-Xaa-Xaa-His) found in cloned delta-12 and delta-15 membrane bound-desaturases (Table 20).

TABLE 20 Alignment of Amino Acid Sequences of Cloned Canola Membrane Bound-Desaturases Desaturase Gene Sequence^(a) Position Canola-fad2-D(mutant) AHKCGH 109-114 of (SEQ ID NO:68) SEQ ID NO:12 Canola-Fad2-D AHECGH 109-114 of (SEQ ID NO:59) SEQ ID NO:10 Canola-Fad2-F AHECGH 109-114 of (SEQ ID NO:59) SEQ ID NO:14 Canola-FadC GHDCAH 170-175 (SEQ ID NO:55) Canola-fad3 (mutant) GHKCGH 94-99 (SEQ ID NO:56) Canola-Fad3 GHDCGH 94-99 (SEQ ID NO:57) Canola-FadD GHDCGH 125-130 (SEQ ID NO:57) (FadD = Plastid delta 15, Fad3 = Microsomal delta-15), (FadC = Plastid delta-12, Fad2 = Microsomal delta-12) ^(a)One letter amino acid code; conservative substitutions are underlined; non-conservative substitutions are in bold.

EXAMPLE 8 Transcription and Translation of Microsomal Delta-12 Fatty Acid Desaturases

Transcription in vivo was analyzed by RT-PCR analysis of stage II and stage III developing seeds and leaf tissue. The primers used to specifically amplify delta-12 desaturase F gene RNA from the indicated tissues were sense primer 5′-GGATATGATGATGGTGAAAGA-3′ (SEQ ID NO:19) and antisense primer 5′-TCTTTCACCATCATCATATCC-3′ (SEQ ID NO:20). The primers used to specifically amplify delta-12 desaturase D gene RNA from the indicated tissues were sense primer 5′-GTTATGAAGCAAAGAAGAAAC-3′ (SEQ ID NO:21) and antisense primer 5′-GTTTCTTCTTTGCTTCATAAC-3′ (SEQ ID NO:22). The results indicated that mRNA of both the D and F gene was expressed in seed and leaf tissues of IMC 129, Q508 and wild type Westar plants.

In vitro transcription and translation analysis showed that a peptide of about 46 kD was made. This is the expected size of both the D gene product and the F gene product, based on sum of the deduced amino acid sequence of each gene and the cotranslational addition of a microsomal membrane peptide.

These results rule out the possibility that non-sense or frameshift mutations, resulting in a truncated polypeptide gene product, are present in either the mutant D gene or the mutant F gene. The data, in conjunction with the data of Example 7, support the conclusion that the mutations in Q508 and IMC 129 are in delta-12 fatty acid desaturase structural genes encoding desaturase enzymes, rather than in regulatory genes.

EXAMPLE 9 Development of Gene-Specific PCR Markers

Based on the single base change in the mutant D gene of IMC 129 described in above, two 5′ PCR primers were designed. The nucleotide sequence of the primers differed only in the base (G for Westar and A for IMC 129) at the 3′ end. The primers allow one to distinguish between mutant fad2-D and wild-type Fad2-D alleles in a DNA-based PCR assay. Since there is only a single base difference in the 5′ PCR primers, the PCR assay is very sensitive to the PCR conditions such as annealing temperature, cycle number, amount, and purity of DNA templates used. Assay conditions have been established that distinguish between the mutant gene and the wild type gene using genomic DNA from IMC 129 and wild type plants as templates. Conditions may be further optimized by varying PCR parameters, particularly with variable crude DNA samples. A PCR assay distinguishing the single base mutation in IMC 129 from the wild type gene along with fatty acid composition analysis provides a means to simplify segregation and selection analysis of genetic crosses involving plants having a delta-12 fatty acid desaturase mutation.

EXAMPLE 10 Transformation with Mutant and Wild Type Fad3 Genes

B. napus cultivar Westar was transformed with mutant and wild type Fad3 genes to demonstrate that the mutant Fad3 gene for canola cytoplasmic linoleic desaturase delta-15 desaturase is nonfunctional. Transformation and regeneration were performed using disarmed Agrobacterium tumefaciens essentially following the procedure described in WO 94/11516.

Two disarmed Agrobacterium strains were engineered, each containing a Ti plasmid having the appropriate gene linked to a seed-specific promoter and a corresponding termination sequence. The first plasmid, pIMC110, was prepared by inserting into a disarmed Ti vector the full length wild type Fad3 gene in sense orientation (nucleotides 208 to 1336 of SEQ ID 6 in WO 93/11245), flanked by a napin promoter sequence positioned 5′ to the Fad3 gene and a napin termination sequence positioned 3′ to the Fad3 gene. The rapeseed napin promoter is described in EP 0255378.

The second plasmid, pIMC205, was prepared by inserting a mutated Fad3 gene in sense orientation into a disarmed Ti vector. The mutant sequence contained mutations at nucleotides 411 and 413 of the microsomal Fad3 gene described in WO93/11245, thus changing the sequence for codon 96 from GAC to AAG. The amino acid at codon 96 of the gene product was thereby changed from aspartic acid to lysine. See Table 20. A bean (Phaseolus vulgaris) phaseolin (7S seed storage protein) promoter fragment of 495 base pairs was placed 5′ to the mutant Fad3 gene and a phaseolin termination sequence was placed 3′ to the mutant Fad3 gene. The phaseolin sequence is described in Doyle et al., (1986) J. Biol. Chem. 261:9228-9238) and Slightom et al., (1983) Proc. Natl. Acad. Sci. USA 80:1897-1901.

The appropriate plasmids were engineered and transferred separately to Agrobacterium strain LBA4404. Each engineered strain was used to infect 5 mm segments of hypocotyl explants from Westar seeds by cocultivation. Infected hypocotyls were transferred to callus medium and, subsequently, to regeneration medium. Once discernable stems formed from the callus, shoots were excised and transferred to elongation medium. The elongated shoots were cut, dipped in Rootone™, rooted on an agar medium and transplanted to potting soil to obtain fertile T1 plants. T2 seeds were obtained by selling the resulting T1 plants.

Fatty acid analysis of T2 seeds was carried out as described above. The results are summarized in Table 21. Of the 40 transformants obtained using the pIMC110 plasmid, 17 plants demonstrated wild type fatty acid profiles and 16 demonstrated overexpression. A proportion of the transformants are expected to display an overexpression phenotype when a functioning gene is transformed in sense orientation into plants.

Of the 307 transformed plants having the pIMC205 gene, none exhibited a fatty acid composition indicative of overexpression. This result indicates that the mutant fad3 gene product is non-functional, since some of the transformants would have exhibited an overexpression phenotype if the gene product were functional.

TABLE 21 Overexpression and Co-suppression Events in Westar Populations Transformed with pIMC205 or pIMC110. α-Linolenic Overexpression Co-Suppression Number of Acid Events Events Wild Type Construct Transformants Range(%) (>10% linolenic) (<4.0% linolenic) Events pIMC110  40 2.4-20.6 16 7  17 pIMC205 307 4.6-10.4  0 0 307

Fatty acid compositions of representative transformed plants are presented in Table 22. Lines 652-09 and 663-40 are representative of plants containing pIMC110 and exhibiting an overexpression and a co-suppression phenotype, respectively. Line 205-284 is representative of plants containing pIMC205 and having the mutant fad3 gene.

TABLE 22 Fatty Acid Composition of T2 Seed From Westar Transformed With pIMC205 or pIMC110. Fatty Acid Composition (%) Line C16:0 C18:0 C18:1 C18:2 C18:3 652-09 pIMC110 4.7 3.3 65.6 8.1 14.8 overexpression 663-40 4.9 2.1 62.5 23.2 3.6 pIMC110 Co-suppression 205-284 3.7 1.8 68.8 15.9 6.7 pIMC205

EXAMPLE 11 Sequences of Wild Type and Mutant Fad2-D and Fad2-F

High molecular weight genomic DNA was isolated from leaves of Q4275 plants (Example 5). This DNA was used as template for amplification of Fad2-D and Fad2-F genes by polymerase chain reaction (PCR). PCR amplifications were carried out in a total volume of 100 μl and contained 0.3 μg genomic DNA, 200 μM deoxyribonucleoside triphosphates, 3 mM MgSO₄, 1-2 Units DNA polymerase and 1×Buffer (supplied by the DNA polymerase manufacturer). Cycle conditions were: 1 cycle for 1 min at 95° C., followed by 30 cycles of 1 min at 94° C., 2 min at 55° C. and 3 min at 73° C.

The Fad2-D gene was amplified once using Elongase® (Gibco-BRL). PCR primers were: 5′-CAUCAUCAUCAUCTTCTTCGTAGGGTTCATCG-3′ (SEQ ID NO:23) and 5′-CUACUACUACUATCATAGAAGAGAAAGGTTCAG-3′ (SEQ ID NO:24) for the 5′ and 3′ ends of the gene, respectively.

The Fad2-F gene was independently amplified 4 times, twice with Elongase® and twice with Taq polymerase (Boehringer Mannheim). The PCR primers used were: 5′CAUCAUCAUCAUCATGGGTGCACGTGGAAGAA3′ (SEQ ID NO:25) and 5′CUACUACUACUATCTTTCACCATCATCATATCC3′ (SEQ ID NO:26) for the 5′ and 3′ ends of the gene, respectively.

Amplified DNA products were resolved on an agarose gel, purified by JetSorb® and then annealed into pAMP1 (Gibco-BRL) via the (CAU)₄ and (CUA)₄ sequences at the ends of the primers, and transformed into E. coli DH5α.

The Fad2-D and Fad2-F inserts were sequenced on both strands with an ABI PRISM 310 automated sequencer (Perkin-Elmer) following the manufacturer's directions, using synthetic primers, AmpliTaq® DNA polymerase and dye terminator.

The Fad2-D gene was found to have an intron upstream of the ATG start codon. As expected, the coding sequence of the gene contained a G to A mutation at nucleotide 316, derived from IMC 129 (FIG. 2).

A single base transversion from G to A at nucleotide 908 was detected in the F gene sequence of the Q4275 amplified products, compared to the wild type F gene sequence (FIG. 2). This mutation changes the codon at amino acid 303 from GGA to GAA, resulting in the non-conservative substitution of a glutamic acid residue for a glycine residue (Table 3 and FIG. 3). Expression of the mutant Q4275 Fad2-F delta-12 desaturase gene in plants alters the fatty acid composition, as described hereinabove.

EXAMPLE 12 High Erucic, High Oleic Acid Rapeseed

The breeding procedure designed to produce novel fatty acid compositions in rapeseed is outlined in FIG. 4. In general, crosses were made between a high erucic acid line and a high oleic acid line. The high erucic acid line, designated HECOL (sold under the trade name Hero), contains about 45.5% erucic acid (Table 23). The high oleic acid lines were designated 93GS66A-130 and 93GS34A-179 and were derived from 93GS. See, for example, Example 5 and Table 17. These lines contain about 84% oleic acid in their seed oil (Table 24).

TABLE 23 Fatty Acid Composition of HEC01 Fatty Acid Weight (%) C_(14:0) 0.05 C_(16.0) 3.60 C_(16:1) 0.36 C_(18:0) 1.66 C_(18:1) 14.72 C_(18:2) 10.67 C_(18:3) 9.71 C_(20:0) 1.36 C_(20:1) 9.04 C_(20:2) 0.48 C_(22:0) 1.74 C_(22:1) 45.45 C_(24:0) 0.49 C_(24:1) 0.81

TABLE 24 Fatty Acid Composition of 93GS66A-130 and 93GS34A-179 Fatty Acid Weight (%) of 93GS66A-130 Weight (%) of 93GS34A-179 C_(14:0) 0.04 0.05 C_(16:0) 3.25 3.23 C_(16:1) 0.25 0.25 C_(18:0) 1.60 1.94 C_(18:1) 84.38 83.71 C_(18:2) 2.58 3.14 C_(18:3) 4.86 4.76 C_(20:0) 0.56 0.65 C_(20:1) 1.57 1.41 C_(20:2) 0.05 0.04 C_(22:0) 0.37 0.39 C_(22:1) 0.06 0.03 C_(24.0) 0.20 0.18 C_(24.1) 0.21 0.18

The F₁ generations of crosses between HEC01 x 93GS66A-130, and HEC01 x 93GS34A-179, were designated 96.801 and 96.804, respectively. F₁ 96.801 and 96.804 plants were self-pollinated to produce F₂ seed. Overall, 622 random single F₂ seeds were analyzed for their fatty acid composition. Table 25 summarizes the average percent and standard deviation for total monounsaturated content, oleic acid, eicosenoic acid, erucic acid, total polyunsaturated and total saturated fatty acid content of these 622 seeds.

TABLE 25 Fatty acid % Total long chain 78.90 ± 4.07 monounsaturated Palmitoleate  0.28 ± 0.06 Oleic Acid 45.33 ± 9.91 Eicosenoic Acid 14.84 ± 2.84 Erucic Acid 17.97 ± 8.9  Nervonic Acid  0.48 ± 0.21 Total polyunsaturated  7.10 ± 1.05 Total saturated 13.99 ± 3.83

Analysis of this data indicate that the frequency distributions deviate from a normal distribution. The total long chain monounsaturated content frequency distribution is slightly skewed to the right (−0.0513), and the eicosenoic acid content distribution is strongly skewed to the right (−1.715). Frequency distributions for oleic acid and erucic acid content are strongly skewed to the left (0.397 and 0.177, respectively). Skewness was calculated using Lotus 1-2-3 for Windows (release 5.0).

Table 26 describes characteristics of selected populations within the total population of seeds. For example, 151 seeds had a long chain monounsaturated fatty acid content greater than 82% (Table 26, column B). Within this population, the average oleic, eicosenoic and erucic acid content was about 48%, 16%, and 19%, respectively. Total polyunsaturated fatty acid content (C18:2, C18:3, and C20:2) was about 9% and total saturated fatty acid content was less than 7%.

Forty-seven of the 622 seeds had a long chain monounsaturated content greater than 85% (Table 26, column C). The average oleic, eicosenoic and erucic acid content within these seeds was 51%, 17%, and 17%, respectively. Total saturated and total polyunsaturated fatty acids were each less than 7%.

Twenty-three of the seeds had an eicosenoic acid content greater than 19% (Table 26, column F). Within these seeds, the average oleic acid erucic acid content was about 44% and 19%, respectively. Total polyunsaturated fatty acids were less than 10% and total saturated fatty acids were less than 7%.

TABLE 26 A B C D E F Total Saturated 6.76 ± 0.72 6.65 ± 0.07 6.68 ± 0.61 6.85 ± 0.98 6.85 ± 0.93 6.66 ± 0.78 C14:0 0.04 ± 0.04 0.07 ± 0.05 0.06 ± 0.03 0.07 ± 0.04 0.06 ± 0.64 0.07 ± 0.05 C16:0 3.42 ± 0.37 3.35 ± 0.34 3.28 ± 0.32 3.45 ± 0.40 3.51 ± 0.42 3.31 ± 0.33 C18:0 1.92 ± 0.33 1.93 ± 0.32 2.06 ± 0.32 1.83 ± 0.30 1.90 ± 0.30 1.93 ± 0.23 C20:0 0.77 ± 0.14 0.76 ± 0.14 0.76 ± 0.13 0.80 ± 0.13 0.76 ± 0.12 0.79 ± 0.16 C22:0 0.38 ± 0.14 0.36 ± 0.12 0.37 ± 0.11 0.42 ± 0.15 0.35 ± 0.12 0.35 ± 0.29 C24:0 0.21 ± 0.19 0.19 ± 0.14 0.20 ± 0.17 0.28 ± 0.76 0.26 ± 0.71 0.19 ± 0.24 Total Monounsaturated 82.91 ± 2.11  84.21 ± 1.64  86.21 ± 1.00  79.49 ± 4.00  80.36 ± 3.75  83.92 ± 2.43  C16:1 0.28 ± 0.05 0.27 ± 0.05 0.27 ± 0.04 0.27 ± 0.05 0.27 ± 0.05 0.26 ± 0.05 C18:1 46.45 ± 9.47  47.66 ± 9.22  51.33 ± 8.96  39.29 ± 6.21  43.55 ± 6.91  44.08 ± 2.89  C20:1 16.91 ± 2.57  16.41 ± 2.47  16.72 ± 2.40  15.56 ± 2.22  16.78 ± 1.30  19.97 ± 0.63  C22:1 19.69 ± 8.45  19.38 ± 8.25  17.39 ± 12.26 23.81 ± 5.89  19.27 ± 6.39  19.09 ± 2.32  C24:1 0.49 ± 0.19 0.48 ± 0.17 0.50 ± 0.18 0.56 ± 0.10 0.49 ± 0.21 0.52 ± 0.29 Total Polyunsaturated 10.33 ± 2.10  9.14 ± 1.71 7.11 ± 0.98 13.66 ± 3.87  12.80 ± 3.60  9.43 ± 2.43 C18:2 5.16 ± 1.5  4.36 ± 1.24 3.17 ± 0.82 7.25 ± 2.62 6.58 ± 2.40 3.96 ± 1.39 C18:3 5.02 ± 1.18 4.65 ± 1.07 3.84 ± 0.69 6.19 ± 1.61 6.02 ± 1.52 5.27 ± 1.25 C20:2 0.15 ± 0.10 0.13 ± 0.04 0.10 ± 0.04 0.22 ± 0.11 0.19 ± 0.10 0.20 ± 0.28 A => 80% total long chain monounsaturated content, n = 247; B => 82% total long chain monounsaturated content, n = 151; C => 85% total long chain monounsaturated content, n = 47; D => 15% erucic acid, n = 318; E => 15% eicosenoic acid, n = 323; F => 19% eicosenoic acid, n = 23

Fatty acid composition of selected single seeds is presented in Table 27. V800655.334 was a single seed that had a long chain monounsaturated fatty acid content of approximately 84%. The oleic acid, eicosenoic acid and erucic acid content was 33.48%, 17.14%, and 32.23%, respectively. The total polyunsaturated fatty acid content was approximately 10%. The linoleic, α-linolenic and erucic acid content was 3.54%, 6.01%, and 0.15%, respectively.

V800655.126 was a single seed that had a long chain monounsaturated fatty acid content of approximately 85% (42.67% oleic acid, 16.21% eicosenoic acid, and 25.37% erucic acid). The total polyunsaturated fatty acid content was approximately 8% (4.87% linoleic acid, 3.05% α-linolenic acid, and 0.13% eicosadienoic acid).

V800654.9 was a single seed that had a long chain monounsaturated fatty acid content of 89% (51.53% oleic acid, 16.94% eicosenoic acid, and 19.24% erucic acid). The total polyunsaturated fatty acid content was approximately 8% (4.87% linoleic acid, 3.05% α-linolenic acid, and 0.13% eicosadienoic acid).

Single seeds having a long chain monounsaturated fatty acid content of at least about 82% and an erucic acid content of at least about 15% were planted in a greenhouse, grown to maturity and self-pollinated. Seed (F₃ generation) from each plant were harvested. A bulk seed sample from each F₂ plant is analyzed for fatty acid composition.

TABLE 27 Fatty Acid Composition of Selected Single Seeds V800655.334 V800655.126 V800654.9 Fatty Acid Weight (%) Weight (%) Weight (%) C_(14:0) 0.07 0.05 0.03 C_(16:0) 3.49 3.52 2.98 C_(16:1) 0.34 0.28 0.28 C_(18:0) 1.64 1.89 1.65 C_(18:1) 33.48 42.67 51.53 C_(18:2) 3.54 4.87 2.09 C_(18:3) 6.01 3.05 3.53 C_(20:0) 0.86 0.87 0.68 C_(20:1) 17.14 16.21 16.94 C_(20:2) 0.15 0.13 0.10 C_(22:0) 0.41 0.35 0.24 C_(22:1) 32.23 25.37 19.24 C_(24:0) 0.12 0.13 0.14 C_(24:1) 0.52 0.61 0.59

Additional crosses were made between Hero and several high oleic lines (Table 28) to increase the seed erucic acid content through a reduction in polyunsaturates content and increase in total monunsaturates content. The high oleic acid lines included 048X058 and Q4275X663-40. The 048X058 line resulted from a cross of two separate transformed lines. The 048X058 line contains a co-suppression event resulting from introduction of the 663-40 transgene described above, and a second co-suppression event resulting from a transgene that includes an oleosin promoter linked to an oleic desaturase gene. The Q4275X663-40 line was derived from a cross of Q4275 (Example 5 and Table 17) by 663-40. The 663-40 line contains a co-suppression event resulting from a transgene that includes a napin promotor linked to a linoleic desaturase gene. Plants of each line were grown in growth chambers under 16 hrs of light at 23/17° C. day/night temperature. Flowers were emasculated prior to opening and covered to prevent cross pollination. On the following day, stigmas of emasulated flowers were pollinated with the desired pollen donor. At pod maturity the F1 seed was harvested.

TABLE 28 High erucic crossing block Source of Male Cross Female Female Male Pheno- Number Parent Phenotype Male Parent Phenotype type 97HEHOA HE101 High 22:1 048X058 High 18:1/ Trans- Low 18:3 genes 97HEHOB HE101 High 22:1 Q4275x663-40 High 18:1/ Mutant/ Low 18:3 Trans- gene 97HEHOC HE101 High 22:1 Q4275x663-40 High 18:1/ Mutant/ Low 18:3 Trans- gene

F1 seed generated from the crosses in Table 28 were advanced to F2 seed generation in the growth chamber. Ten seeds were individually planted for each cross. At flowering the plants were covered with bags to ensure self pollination. The F2 seeds were harvested at maturity.

The seeds were germinated on filter paper at room temperature in the dark. Eighteen to 24 hours after the start of germination, one cotyledon was removed from the seed for extraction of fatty acids. Fatty acid compositions were determined using gas chromatography. Selected F2 half seeds having a high erucic content are shown in Tables 29 and 30.

TABLE 29 Half Seed Selection on F2 Seed of 97HEHOA [HE101X(048X052)] Fatty Acid Composition (%) Sample No. C16:0 C18:0 C18:1 C18:2 C18:3 C20:0 C20:1 C22:0 C22:1 C24:0 C24:1 VL10186-1 3.34 1.83 49.7 3.32 1.59 0.87 19.62 0.30 18.10 0.39 0.35 VL10186-5 2.61 1.07 29.14 5.81 2.42 0.71 14.99 0.31 40.90 0.93 0.60 VL10186-33 3.47 1.32 29.73 4.38 2.98 0.86 12.22 0.44 41.21 1.50 1.28 VL10186-59 4.01 1.68 41.38 2.96 1.69 1.08 19.72 0.43 26.05 0 0.55 VL10186-67 3.90 1.29 29.10 3.65 2.89 0.88 13.79 0.52 40.96 1.31 1.09 VL10186-74 2.76 1.25 34.04 2.63 1.45 0.75 16.64 0.38 38.67 0.14 0.95 VL10186-88 3.23 1.39 48.97 3.27 1.50 0.60 19.71 0.17 20.48 0 0.36

TABLE 30 Half Seed Selection on F2 Seed of 97HEHOC [HE101X(Q4275X663-40)] Fatty Acid Composition (%) Sample No. C16:0 C18:0 C18:1 C18:2 C18:3 C20:0 C20:1 C22:0 C22:1 C24:0 C24:1 VL10200- 2.24 0.74 31.66 3.01 6.24 0.46 11.79 0.41 40.60 0.86 1.57 214 VL10200- 3.89 1.03 31.51 12.50 2.41 0.54 14.17 0.29 32.23 0 0.75 231 VL10200- 3.36 0.95 33.19 8.99 1.66 0.55 14.35 0.21 33.61 0.83 1.02 238 VL10200- 3.12 1.02 30.18 7.61 1.52 0.59 14.53 0.19 39.41 0.24 1.013 267 VL10203-50 2.63 0.97 31.79 8.47 1.99 0.58 14.58 0.25 37.41 0.13 0.59 VL10200- 2.71 0.78 32.83 6.85 1.88 0.46 13.11 0.32 39.18 0.82 0.67 293

Selected half seeds were planted in soil and grown under growth chamber conditions described above. At flowering the plants were covered with bags for self pollination. After maturity, the F3 selfed seed was harvested and analyzed for fatty acid composition. Seeds were analyzed using a 10-15 seed sample size. The results of the analysis are in Tables 31 and 32.

TABLE 31 Fatty acid composition of selfed F3 lines of 97HEHOA [HE101X(048X052)] Fatty Acid Composition (%) Sample No. C16:0 C18:0 C18:1 C18:2 C18:3 C20:0 C20:1 C22:0 C22:1 C24:0 C24:1 97HEIIOA- 2.51 1.03 27.44 3.72 3.55 0.65 13.60 0.30 45.57 0.14 1.03 74 97HEIIOA- 3.66 1.40 47.79 6.47 2.97 0.62 19.23 0.25 16.11 0.14 0.76 01 97HEIIOA- 2.47 0.84 20.43 7.25 3.89 0.69 10.33 0.47 52.09 0.16 0.86 67 97HEIIOA- 2.81 1.08 27.01 7.88 2.82 0.69 16.15 0.32 39.68 0.15 0.86 59 97HEHOA- 3.16 1.21 44.85 9.21 2.31 0.49 16.30 0.21 21.00 0.12 0.58 88 97HEHOA- 2.53 0.79 21.90 9.52 3.55 0.53 11.51 0.31 47.59 0.13 1.08 33 97HEHOA-5 2.93 1.01 23.67 10.26 2.00 0.63 14.34 0.38 42.98 0.15 1.06

TABLE 32 Fatty acid composition of selfed F3 lines of 97HEHOC [HE101X(Q4275X663-40)] Fatty Acid Composition (%) Sample No. C16:0 C18:0 C18:1 C18:2 C18:3 C20:0 C20:1 C22:0 C22:1 C24:0 C24:1 97HEHOC-214 2.47 1.12 31.15 3.77 3.84 0.77 13.78 0.43 41.15 0.17 0.97 97HEHOC-267 2.62 1.42 31.64 6.44 1.30 0.84 15.64 0.39 38.15 0.16 0.95 97HEHOC-293 2.73 1.13 32.08 7.23 2.18 0.72 14.88 0.41 37.17 0.17 0.81 97HEHOC-238 2.90 1.05 35.20 9.37 1.76 0.66 14.88 0.38 32.05 0.1 1.01 97HEHOC(2)-50 2.60 0.93 31.16 5.66 2.09 0.61 14.93 0.31 40.30 0.11 0.88 97HEHOC(2)-156 3.19 1.71 46.56 3.05 1.59 0.94 16.41 0.40 24.67 0.19 0.83

To the extent not already indicated, it will be understood by those of ordinary skill in the art that any one of the various specific embodiments herein described and illustrated may be further modified to incorporate features shown in other of the specific embodiments.

The foregoing detailed description has been provided for a better understanding of the invention only and no unnecessary limitation should be understood therefrom as some modifications will be apparent to those skilled in the art without deviating from the spirit and scope of the appended claims.

                   #             SEQUENCE LISTING <160> NUMBER OF SEQ ID NOS: 68 <210> SEQ ID NO 1 <211> LENGTH: 1155 <212> TYPE: DNA <213> ORGANISM: Brassica napus <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)...(1152) <223> OTHER INFORMATION: Wild type Fad2 <221> NAME/KEY: misc_feature <222> LOCATION: 205 <223> OTHER INFORMATION: n = a, g, c, or  #t <400> SEQUENCE: 1 atg ggt gca ggt gga aga atg caa gtg tct cc #t ccc tcc aag aag tct       48 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 gaa acc gac acc atc aag cgc gta ccc tgc ga #g aca ccg ccc ttc act       96 Glu Thr Asp Thr Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 gtc gga gaa ctc aag aaa gca atc cca ccg ca #c tgt ttc aaa cgc tcg      144 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 atc cct cgc tct ttc tcc tac ctc atc tgg ga #c atc atc ata gcc tcc      192 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 tgc ttc tac tac ntc gcc acc act tac ttc cc #t ctc ctc cct cac cct      240 Cys Phe Tyr Tyr Xaa Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 ctc tcc tac ttc gcc tgg cct ctc tac tgg gc #c tgc caa ggg tgc gtc      288 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 cta acc ggc gtc tgg gtc ata gcc cac gaa tg #c ggc cac cac gcc ttc      336 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 agc gac tac cag tgg ctt gac gac acc gtc gg #t ctc atc ttc cac tcc      384 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 ttc ctc ctc gtc cct tac ttc tcc tgg aag ta #c agt cat cgc agc cac      432 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Ser His     130               #   135               #   140 cat tcc aac act ggc tcc ctc gag aga gac ga #a gtg ttt gtc ccc aag      480 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 aag aag tca gac atc aag tgg tac ggc aag ta #c ctc aac aac cct ttg      528 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 gga cgc acc gtg atg tta acg gtt cag ttc ac #t ctc ggc tgg ccg ttg      576 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 tac tta gcc ttc aac gtc tcg gga aga cct ta #c gac ggc ggc ttc cgt      624 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Arg         195           #       200           #       205 tgc cat ttc cac ccc aac gct ccc atc tac aa #c gac cgc gag cgt ctc      672 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 cag ata tac atc tcc gac gct ggc atc ctc gc #c gtc tgc tac ggt ctc      720 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 ttc cgt tac gcc gcc ggc cag gga gtg gcc tc #g atg gtc tgc ttc tac      768 Phe Arg Tyr Ala Ala Gly Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 gga gtc ccg ctt ctg att gtc aat ggt ttc ct #c gtg ttg atc act tac      816 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 ttg cag cac acg cat cct tcc ctg cct cac ta #c gat tcg tcc gag tgg      864 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 gat tgg ttc agg gga gct ttg gct acc gtt ga #c aga gac tac gga atc      912 Asp Trp Phe Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 ttg aac aag gtc ttc cac aat att acc gac ac #g cac gtg gcc cat cat      960 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 ccg ttc tcc acg atg ccg cat tat cac gcg at #g gaa gct acc aag gcg     1008 Pro Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 ata aag ccg ata ctg gga gag tat tat cag tt #c gat ggg acg ccg gtg     1056 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 gtt aag gcg atg tgg agg gag gcg aag gag tg #t atc tat gtg gaa ccg     1104 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 gac agg caa ggt gag aag aaa ggt gtg ttc tg #g tac aac aat aag tta     1152 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 tga                   #                   #                   #           1155 <210> SEQ ID NO 2 <211> LENGTH: 384 <212> TYPE: PRT <213> ORGANISM: Brassica napus <220> FEATURE: <223> OTHER INFORMATION: Xaa = Phe, Leu, Ile #, or Val <400> SEQUENCE: 2 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 Glu Thr Asp Thr Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 Cys Phe Tyr Tyr Xaa Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Ser His     130               #   135               #   140 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Arg         195           #       200           #       205 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 Phe Arg Tyr Ala Ala Gly Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 Asp Trp Phe Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 Pro Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 <210> SEQ ID NO 3 <211> LENGTH: 1155 <212> TYPE: DNA <213> ORGANISM: Brassica napus <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)...(1152) <223> OTHER INFORMATION: g to a transversion mu #tation at nucleotide 316 <221> NAME/KEY: misc_feature <222> LOCATION: 205 <223> OTHER INFORMATION: n = a, g, c, or  #t/u <400> SEQUENCE: 3 atg ggt gca ggt gga aga atg caa gtg tct cc #t ccc tcc aag aag tct       48 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 gaa acc gac acc atc aag cgc gta ccc tgc ga #g aca ccg ccc ttc act       96 Glu Thr Asp Thr Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 gtc gga gaa ctc aag aaa gca atc cca ccg ca #c tgt ttc aaa cgc tcg      144 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 atc cct cgc tct ttc tcc tac ctc atc tgg ga #c atc atc ata gcc tcc      192 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 tgc ttc tac tac ntc gcc acc act tac ttc cc #t ctc ctc cct cac cct      240 Cys Phe Tyr Tyr Xaa Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 ctc tcc tac ttc gcc tgg cct ctc tac tgg gc #c tgc caa ggg tgc gtc      288 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 cta acc ggc gtc tgg gtc ata gcc cac aag tg #c ggc cac cac gcc ttc      336 Leu Thr Gly Val Trp Val Ile Ala His Lys Cy #s Gly His His Ala Phe             100       #           105       #           110 agc gac tac cag tgg ctt gac gac acc gtc gg #t ctc atc ttc cac tcc      384 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 ttc ctc ctc gtc cct tac ttc tcc tgg aag ta #c agt cat cgc agc cac      432 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Ser His     130               #   135               #   140 cat tcc aac act ggc tcc ctc gag aga gac ga #a gtg ttt gtc ccc aag      480 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 aag aag tca gac atc aag tgg tac ggc aag ta #c ctc aac aac cct ttg      528 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 gga cgc acc gtg atg tta acg gtt cag ttc ac #t ctc ggc tgg ccg ttg      576 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 tac tta gcc ttc aac gtc tcg gga aga cct ta #c gac ggc ggc ttc cgt      624 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Arg         195           #       200           #       205 tgc cat ttc cac ccc aac gct ccc atc tac aa #c gac cgc gag cgt ctc      672 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 cag ata tac atc tcc gac gct ggc atc ctc gc #c gtc tgc tac ggt ctc      720 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 ttc cgt tac gcc gcc ggc cag gga gtg gcc tc #g atg gtc tgc ttc tac      768 Phe Arg Tyr Ala Ala Gly Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 gga gtc ccg ctt ctg att gtc aat ggt ttc ct #c gtg ttg atc act tac      816 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 ttg cag cac acg cat cct tcc ctg cct cac ta #c gat tcg tcc gag tgg      864 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 gat tgg ttc agg gga gct ttg gct acc gtt ga #c aga gac tac gga atc      912 Asp Trp Phe Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 ttg aac aag gtc ttc cac aat att acc gac ac #g cac gtg gcc cat cat      960 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 ccg ttc tcc acg atg ccg cat tat cac gcg at #g gaa gct acc aag gcg     1008 Pro Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 ata aag ccg ata ctg gga gag tat tat cag tt #c gat ggg acg ccg gtg     1056 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 gtt aag gcg atg tgg agg gag gcg aag gag tg #t atc tat gtg gaa ccg     1104 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 gac agg caa ggt gag aag aaa ggt gtg ttc tg #g tac aac aat aag tta     1152 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 tga                   #                   #                   #           1155 <210> SEQ ID NO 4 <211> LENGTH: 384 <212> TYPE: PRT <213> ORGANISM: Brassica napus <220> FEATURE: <223> OTHER INFORMATION: Xaa = Phe, Leu, Ile #, or Val <400> SEQUENCE: 4 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 Glu Thr Asp Thr Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 Cys Phe Tyr Tyr Xaa Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 Leu Thr Gly Val Trp Val Ile Ala His Lys Cy #s Gly His His Ala Phe             100       #           105       #           110 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Ser His     130               #   135               #   140 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Arg         195           #       200           #       205 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 Phe Arg Tyr Ala Ala Gly Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 Asp Trp Phe Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 Pro Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 <210> SEQ ID NO 5 <211> LENGTH: 1155 <212> TYPE: DNA <213> ORGANISM: Brassica napus <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)...(1152) <223> OTHER INFORMATION: Wild type Fad2 <400> SEQUENCE: 5 atg ggt gca ggt gga aga atg caa gtg tct cc #t ccc tcc aaa aag tct       48 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 gaa acc gac aac atc aag cgc gta ccc tgc ga #g aca ccg ccc ttc act       96 Glu Thr Asp Asn Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 gtc gga gaa ctc aag aaa gca atc cca ccg ca #c tgt ttc aaa cgc tcg      144 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 atc cct cgc tct ttc tcc tac ctc atc tgg ga #c atc atc ata gcc tcc      192 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 tgc ttc tac tac gtc gcc acc act tac ttc cc #t ctc ctc cct cac cct      240 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 ctc tcc tac ttc gcc tgg cct ctc tac tgg gc #c tgc cag ggc tgc gtc      288 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 cta acc ggc gtc tgg gtc ata gcc cac gag tg #c ggc cac cac gcc ttc      336 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 agc gac tac cag tgg ctg gac gac acc gtc gg #c ctc atc ttc cac tcc      384 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 ttc ctc ctc gtc cct tac ttc tcc tgg aag ta #c agt cat cga cgc cac      432 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 cat tcc aac act ggc tcc ctc gag aga gac ga #a gtg ttt gtc ccc aag      480 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 aag aag tca gac atc aag tgg tac ggc aag ta #c ctc aac aac cct ttg      528 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 gga cgc acc gtg atg tta acg gtt cag ttc ac #t ctc ggc tgg cct ttg      576 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 tac tta gcc ttc aac gtc tcg ggg aga cct ta #c gac ggc ggc ttc gct      624 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 tgc cat ttc cac ccc aac gct ccc atc tac aa #c gac cgc gag cgt ctc      672 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 cag ata tac atc tcc gac gct ggc atc ctc gc #c gtc tgc tac ggt ctc      720 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 tac cgc tac gct gct gtc caa gga gtt gcc tc #g atg gtc tgc ttc tac      768 Tyr Arg Tyr Ala Ala Val Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 gga gtt ccg ctt ctg att gtc aat ggg ttc tt #a gtt ttg atc act tac      816 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 ttg cag cac acg cat cct tcc ctg cct cac ta #t gac tcg tct gag tgg      864 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 gat tgg ttg agg gga gct ttg gcc acc gtt ga #c aga gac tac gga atc      912 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 ttg aac aag gtc ttc cac aat atc acg gac ac #g cac gtg gcg cat cac      960 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 ctg ttc tcg acc atg ccg cat tat cat gcg at #g gaa gct acg aag gcg     1008 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 ata aag ccg ata ctg gga gag tat tat cag tt #g cat ggg acg ccg gtg     1056 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Le #u His Gly Thr Pro Val             340       #           345       #           350 gtt aag gcg atg tgg agg gag gcg aag gag tg #t atc tat gtg gaa ccg     1104 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 gac agg caa ggt gag aag aaa ggt gtg ttc tg #g tac aac aat aag tta     1152 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 tga                   #                   #                   #           1155 <210> SEQ ID NO 6 <211> LENGTH: 384 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 6 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 Glu Thr Asp Asn Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 Tyr Arg Tyr Ala Ala Val Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Le #u His Gly Thr Pro Val             340       #           345       #           350 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 <210> SEQ ID NO 7 <211> LENGTH: 1155 <212> TYPE: DNA <213> ORGANISM: Brassica napus <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)...(1152) <223> OTHER INFORMATION: T to A transversion mu #tation at nucleotide 515 <400> SEQUENCE: 7 atg ggt gca ggt gga aga atg caa gtg tct cc #t ccc tcc aaa aag tct       48 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 gaa acc gac aac atc aag cgc gta ccc tgc ga #g aca ccg ccc ttc act       96 Glu Thr Asp Asn Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 gtc gga gaa ctc aag aaa gca atc cca ccg ca #c tgt ttc aaa cgc tcg      144 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 atc cct cgc tct ttc tcc tac ctc atc tgg ga #c atc atc ata gcc tcc      192 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 tgc ttc tac tac gtc gcc acc act tac ttc cc #t ctc ctc cct cac cct      240 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 ctc tcc tac ttc gcc tgg cct ctc tac tgg gc #c tgc cag ggc tgc gtc      288 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 cta acc ggc gtc tgg gtc ata gcc cac gag tg #c ggc cac cac gcc ttc      336 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 agc gac tac cag tgg ctg gac gac acc gtc gg #c ctc atc ttc cac tcc      384 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 ttc ctc ctc gtc cct tac ttc tcc tgg aag ta #c agt cat cga cgc cac      432 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 cat tcc aac act ggc tcc ctc gag aga gac ga #a gtg ttt gtc ccc aag      480 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 aag aag tca gac atc aag tgg tac ggc aag ta #c cac aac aac cct ttg      528 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r His Asn Asn Pro Leu                 165   #               170   #               175 gga cgc acc gtg atg tta acg gtt cag ttc ac #t ctc ggc tgg cct ttg      576 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 tac tta gcc ttc aac gtc tcg ggg aga cct ta #c gac ggc ggc ttc gct      624 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 tgc cat ttc cac ccc aac gct ccc atc tac aa #c gac cgc gag cgt ctc      672 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 cag ata tac atc tcc gac gct ggc atc ctc gc #c gtc tgc tac ggt ctc      720 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 tac cgc tac gct gct gtc caa gga gtt gcc tc #g atg gtc tgc ttc tac      768 Tyr Arg Tyr Ala Ala Val Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 gga gtt ccg ctt ctg att gtc aat ggg ttc tt #a gtt ttg atc act tac      816 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 ttg cag cac acg cat cct tcc ctg cct cac ta #t gac tcg tct gag tgg      864 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 gat tgg ttg agg gga gct ttg gcc acc gtt ga #c aga gac tac gga atc      912 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 ttg aac aag gtc ttc cac aat atc acg gac ac #g cac gtg gcg cat cac      960 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 ctg ttc tcg acc atg ccg cat tat cat gcg at #g gaa gct acg aag gcg     1008 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 ata aag ccg ata ctg gga gag tat tat cag tt #g cat ggg acg ccg gtg     1056 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Le #u His Gly Thr Pro Val             340       #           345       #           350 gtt aag gcg atg tgg agg gag gcg aag gag tg #t atc tat gtg gaa ccg     1104 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 gac agg caa ggt gag aag aaa ggt gtg ttc tg #g tac aac aat aag tta     1152 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 tga                   #                   #                   #           1155 <210> SEQ ID NO 8 <211> LENGTH: 384 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 8 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 Glu Thr Asp Asn Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r His Asn Asn Pro Leu                 165   #               170   #               175 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 Tyr Arg Tyr Ala Ala Val Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Le #u His Gly Thr Pro Val             340       #           345       #           350 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 <210> SEQ ID NO 9 <211> LENGTH: 1155 <212> TYPE: DNA <213> ORGANISM: Brassica napus <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)...(1152) <400> SEQUENCE: 9 atg ggt gca ggt gga aga atg caa gtg tct cc #t ccc tcc aaa aag tct       48 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 gaa acc gac aac atc aag cgc gta ccc tgc ga #g aca ccg ccc ttc act       96 Glu Thr Asp Asn Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 gtc gga gaa ctc aag aaa gca atc cca ccg ca #c tgt ttc aaa cgc tcg      144 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 atc cct cgc tct ttc tcc tac ctc atc tgg ga #c atc atc ata gcc tcc      192 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 tgc ttc tac tac gtc gcc acc act tac ttc cc #t ctc ctc cct cac cct      240 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 ctc tcc tac ttc gcc tgg cct ctc tac tgg gc #c tgc cag ggc tgc gtc      288 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 cta acc ggc gtc tgg gtc ata gcc cac gag tg #c ggc cac cac gcc ttc      336 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 agc gac tac cag tgg ctg gac gac acc gtc gg #c ctc atc ttc cac tcc      384 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 ttc ctc ctc gtc cct tac ttc tcc tgg aag ta #c agt cat cga cgc cac      432 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 cat tcc aac act ggc tcc ctc gag aga gac ga #a gtg ttt gtc ccc aag      480 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 aag aag tca gac atc aag tgg tac ggc aag ta #c ctc aac aac cct ttg      528 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 gga cgc acc gtg atg tta acg gtt cag ttc ac #t ctc ggc tgg cct ttg      576 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 tac tta gcc ttc aac gtc tcg ggg aga cct ta #c gac ggc ggc ttc gct      624 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 tgc cat ttc cac ccc aac gct ccc atc tac aa #c gac cgt gag cgt ctc      672 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 cag ata tac atc tcc gac gct ggc atc ctc gc #c gtc tgc tac ggt ctc      720 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 tac cgc tac gct gct gtc caa gga gtt gcc tc #g atg gtc tgc ttc tac      768 Tyr Arg Tyr Ala Ala Val Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 gga gtt cct ctt ctg att gtc aac ggg ttc tt #a gtt ttg atc act tac      816 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 ttg cag cac acg cat cct tcc ctg cct cac ta #t gac tcg tct gag tgg      864 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 gat tgg ttg agg gga gct ttg gcc acc gtt ga #c aga gac tac gga atc      912 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 ttg aac aag gtc ttc cac aat atc acg gac ac #g cac gtg gcg cat cac      960 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 ctg ttc tcg acc atg ccg cat tat cat gcg at #g gaa gct acg aag gcg     1008 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 ata aag ccg ata ctg gga gag tat tat cag tt #c gat ggg acg ccg gtg     1056 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 gtt aag gcg atg tgg agg gag gcg aag gag tg #t atc tat gtg gaa ccg     1104 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 gac agg caa ggt gag aag aaa ggt gtg ttc tg #g tac aac aat aag tta     1152 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 tga                   #                   #                   #           1155 <210> SEQ ID NO 10 <211> LENGTH: 384 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 10 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 Glu Thr Asp Asn Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                 85   #                90   #                95 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 Tyr Arg Tyr Ala Ala Val Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 <210> SEQ ID NO 11 <211> LENGTH: 1155 <212> TYPE: DNA <213> ORGANISM: Brassica napus <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)...(1152) <400> SEQUENCE: 11 atg ggt gca ggt gga aga atg caa gtg tct cc #t ccc tcc aaa aag tct       48 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 gaa acc gac aac atc aag cgc gta ccc tgc ga #g aca ccg ccc ttc act       96 Glu Thr Asp Asn Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 gtc gga gaa ctc aag aaa gca atc cca ccg ca #c tgt ttc aaa cgc tcg      144 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 atc cct cgc tct ttc tcc tac ctc atc tgg ga #c atc atc ata gcc tcc      192 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 tgc ttc tac tac gtc gcc acc act tac ttc cc #t ctc ctc cct cac cct      240 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 ctc tcc tac ttc gcc tgg cct ctc tac tgg gc #c tgc cag ggc tgc gtc      288 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 cta acc ggc gtc tgg gtc ata gcc cac aag tg #c ggc cac cac gcc ttc      336 Leu Thr Gly Val Trp Val Ile Ala His Lys Cy #s Gly His His Ala Phe             100       #           105       #           110 agc gac tac cag tgg ctg gac gac acc gtc gg #c ctc atc ttc cac tcc      384 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 ttc ctc ctc gtc cct tac ttc tcc tgg aag ta #c agt cat cga cgc cac      432 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 cat tcc aac act ggc tcc ctc gag aga gac ga #a gtg ttt gtc ccc aag      480 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 aag aag tca gac atc aag tgg tac ggc aag ta #c ctc aac aac cct ttg      528 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 gga cgc acc gtg atg tta acg gtt cag ttc ac #t ctc ggc tgg cct ttg      576 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 tac tta gcc ttc aac gtc tcg ggg aga cct ta #c gac ggc ggc ttc gct      624 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 tgc cat ttc cac ccc aac gct ccc atc tac aa #c gac cgt gag cgt ctc      672 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 cag ata tac atc tcc gac gct ggc atc ctc gc #c gtc tgc tac ggt ctc      720 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 tac cgc tac gct gct gtc caa gga gtt gcc tc #g atg gtc tgc ttc tac      768 Tyr Arg Tyr Ala Ala Val Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 gga gtt cct ctt ctg att gtc aac ggg ttc tt #a gtt ttg atc act tac      816 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 ttg cag cac acg cat cct tcc ctg cct cac ta #t gac tcg tct gag tgg      864 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 gat tgg ttg agg gga gct ttg gcc acc gtt ga #c aga gac tac gga atc      912 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 ttg aac aag gtc ttc cac aat atc acg gac ac #g cac gtg gcg cat cac      960 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 ctg ttc tcg acc atg ccg cat tat cat gcg at #g gaa gct acg aag gcg     1008 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 ata aag ccg ata ctg gga gag tat tat cag tt #c gat ggg acg ccg gtg     1056 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 gtt aag gcg atg tgg agg gag gcg aag gag tg #t atc tat gtg gaa ccg     1104 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 gac agg caa ggt gag aag aaa ggt gtg ttc tg #g tac aac aat aag tta     1152 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 tga                   #                   #                   #           1155 <210> SEQ ID NO 12 <211> LENGTH: 384 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 12 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 Glu Thr Asp Asn Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 Leu Thr Gly Val Trp Val Ile Ala His Lys Cy #s Gly His His Ala Phe             100       #           105       #           110 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 Tyr Arg Tyr Ala Ala Val Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 <210> SEQ ID NO 13 <211> LENGTH: 1155 <212> TYPE: DNA <213> ORGANISM: Brassica napus <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)...(1152) <400> SEQUENCE: 13 atg ggt gca ggt gga aga atg caa gtg tct cc #t ccc tcc aag aag tct       48 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 gaa acc gac acc atc aag cgc gta ccc tgc ga #g aca ccg ccc ttc act       96 Glu Thr Asp Thr Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 gtc gga gaa ctc aag aaa gca atc cca ccg ca #c tgt ttc aaa cgc tcg      144 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 atc cct cgc tct ttc tcc tac ctc atc tgg ga #c atc atc ata gcc tcc      192 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 tgc ttc tac tac gtc gcc acc act tac ttc cc #t ctc ctc cct cac cct      240 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 ctc tcc tac ttc gcc tgg cct ctc tac tgg gc #c tgc caa ggg tgc gtc      288 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 cta acc ggc gtc tgg gtc ata gcc cac gag tg #c ggc cac cac gcc ttc      336 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 agc gac tac cag tgg ctt gac gac acc gtc gg #t ctc atc ttc cac tcc      384 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 ttc ctc ctc gtc cct tac ttc tcc tgg aag ta #c agt cat cga cgc cac      432 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 cat tcc aac act ggc tcc ctc gag aga gac ga #a gtg ttt gtc ccc aag      480 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 aag aag tca gac atc aag tgg tac ggc aag ta #c ctc aac aac cct ttg      528 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 gga cgc acc gtg atg tta acg gtt cag ttc ac #t ctc ggc tgg ccg ttg      576 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 tac tta gcc ttc aac gtc tcg gga aga cct ta #c gac ggc ggc ttc gct      624 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 tgc cat ttc cac ccc aac gct ccc atc tac aa #c gac cgc gag cgt ctc      672 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 cag ata tac atc tcc gac gct ggc atc ctc gc #c gtc tgc tac ggt ctc      720 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 ttc cgt tac gcc gcc gcg cag gga gtg gcc tc #g atg gtc tgc ttc tac      768 Phe Arg Tyr Ala Ala Ala Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 gga gtc ccg ctt ctg att gtc aat ggt ttc ct #c gtg ttg atc act tac      816 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 ttg cag cac acg cat cct tcc ctg cct cac ta #c gat tcg tcc gag tgg      864 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 gat tgg ttg agg gga gct ttg gct acc gtt ga #c aga gac tac gga atc      912 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 ttg aac aag gtc ttc cac aat att acc gac ac #g cac gtg gcg cat cat      960 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 ctg ttc tcc acg atg ccg cat tat cac gcg at #g gaa gct acc aag gcg     1008 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 ata aag ccg ata ctg gga gag tat tat cag tt #c gat ggg acg ccg gtg     1056 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 gtt aag gcg atg tgg agg gag gcg aag gag tg #t atc tat gtg gaa ccg     1104 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 gac agg caa ggt gag aag aaa ggt gtg ttc tg #g tac aac aat aag tta     1152 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 tga                   #                   #                   #           1155 <210> SEQ ID NO 14 <211> LENGTH: 384 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 14 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 Glu Thr Asp Thr Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 Phe Arg Tyr Ala Ala Ala Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 <210> SEQ ID NO 15 <211> LENGTH: 1155 <212> TYPE: DNA <213> ORGANISM: Brassica napus <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)...(1152) <400> SEQUENCE: 15 atg ggt gca ggt gga aga atg caa gtg tct cc #t ccc tcc aag aag tct       48 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 gaa acc gac acc atc aag cgc gta ccc tgc ga #g aca ccg ccc ttc act       96 Glu Thr Asp Thr Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 gtc gga gaa ctc aag aaa gca atc cca ccg ca #c tgt ttc aaa cgc tcg      144 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 atc cct cgc tct ttc tcc tac ctc atc tgg ga #c atc atc ata gcc tcc      192 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 tgc ttc tac tac gtc gcc acc act tac ttc cc #t ctc ctc cct cac cct      240 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 ctc tcc tac ttc gcc tgg cct ctc tac tgg gc #c tgc caa ggg tgc gtc      288 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 cta acc ggc gtc tgg gtc ata gcc cac gag tg #c ggc cac cac gcc ttc      336 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 agc gac tac cag tgg ctt gac gac acc gtc gg #t ctc atc ttc cac tcc      384 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 ttc ctc ctc gtc cct tac ttc tcc tgg aag ta #c agt cat cga cgc cac      432 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 cat tcc aac act ggc tcc ctc gag aga gac ga #a gtg ttt gtc ccc aag      480 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 aag aag tca gac atc aag tgg tac ggc aag ta #c cac aac aac cct ttg      528 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r His Asn Asn Pro Leu                 165   #               170   #               175 gga cgc acc gtg atg tta acg gtt cag ttc ac #t ctc ggc tgg ccg ttg      576 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 tac tta gcc ttc aac gtc tcg gga aga cct ta #c gac ggc ggc ttc gct      624 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 tgc cat ttc cac ccc aac gct ccc atc tac aa #c gac cgc gag cgt ctc      672 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 cag ata tac atc tcc gac gct ggc atc ctc gc #c gtc tgc tac ggt ctc      720 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 ttc cgt tac gcc gcc gcg cag gga gtg gcc tc #g atg gtc tgc ttc tac      768 Phe Arg Tyr Ala Ala Ala Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 gga gtc ccg ctt ctg att gtc aat ggt ttc ct #c gtg ttg atc act tac      816 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 ttg cag cac acg cat cct tcc ctg cct cac ta #c gat tcg tcc gag tgg      864 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 gat tgg ttg agg gga gct ttg gct acc gtt ga #c aga gac tac gga atc      912 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 ttg aac aag gtc ttc cac aat att acc gac ac #g cac gtg gcg cat cat      960 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 ctg ttc tcc acg atg ccg cat tat cac gcg at #g gaa gct acc aag gcg     1008 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 ata aag ccg ata ctg gga gag tat tat cag tt #c gat ggg acg ccg gtg     1056 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 gtt aag gcg atg tgg agg gag gcg aag gag tg #t atc tat gtg gaa ccg     1104 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 gac agg caa ggt gag aag aaa ggt gtg ttc tg #g tac aac aat aag tta     1152 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 tga                   #                   #                   #           1155 <210> SEQ ID NO 16 <211> LENGTH: 384 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 16 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 Glu Thr Asp Thr Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r His Asn Asn Pro Leu                 165   #               170   #               175 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 Phe Arg Tyr Ala Ala Ala Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Gly Ile     290               #   295               #   300 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 <210> SEQ ID NO 17 <211> LENGTH: 1155 <212> TYPE: DNA <213> ORGANISM: Brassica napus <220> FEATURE: <221> NAME/KEY: CDS <222> LOCATION: (1)...(1152) <400> SEQUENCE: 17 atg ggt gca ggt gga aga atg caa gtg tct cc #t ccc tcc aag aag tct       48 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 gaa acc gac acc atc aag cgc gta ccc tgc ga #g aca ccg ccc ttc act       96 Glu Thr Asp Thr Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 gtc gga gaa ctc aag aaa gca atc cca ccg ca #c tgt ttc aaa cgc tcg      144 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 atc cct cgc tct ttc tcc tac ctc atc tgg ga #c atc atc ata gcc tcc      192 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 tgc ttc tac tac gtc gcc acc act tac ttc cc #t ctc ctc cct cac cct      240 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 ctc tcc tac ttc gcc tgg cct ctc tac tgg gc #c tgc caa ggg tgc gtc      288 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 cta acc ggc gtc tgg gtc ata gcc cac gag tg #c ggc cac cac gcc ttc      336 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 agc gac tac cag tgg ctt gac gac acc gtc gg #t ctc atc ttc cac tcc      384 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 ttc ctc ctc gtc cct tac ttc tcc tgg aag ta #c agt cat cga cgc cac      432 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 cat tcc aac act ggc tcc ctc gag aga gac ga #a gtg ttt gtc ccc aag      480 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 aag aag tca gac atc aag tgg tac ggc aag ta #c ctc aac aac cct ttg      528 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 gga cgc acc gtg atg tta acg gtt cag ttc ac #t ctc ggc tgg ccg ttg      576 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 tac tta gcc ttc aac gtc tcg gga aga cct ta #c gac ggc ggc ttc gct      624 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 tgc cat ttc cac ccc aac gct ccc atc tac aa #c gac cgc gag cgt ctc      672 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 cag ata tac atc tcc gac gct ggc atc ctc gc #c gtc tgc tac ggt ctc      720 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 ttc cgt tac gcc gcc gcg cag gga gtg gcc tc #g atg gtc tgc ttc tac      768 Phe Arg Tyr Ala Ala Ala Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 gga gtc ccg ctt ctg att gtc aat ggt ttc ct #c gtg ttg atc act tac      816 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 ttg cag cac acg cat cct tcc ctg cct cac ta #c gat tcg tcc gag tgg      864 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 gat tgg ttg agg gga gct ttg gct acc gtt ga #c aga gac tac gaa atc      912 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Glu Ile     290               #   295               #   300 ttg aac aag gtc ttc cac aat att acc gac ac #g cac gtg gcg cat cat      960 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 ctg ttc tcc acg atg ccg cat tat cac gcg at #g gaa gct acc aag gcg     1008 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 ata aag ccg ata ctg gga gag tat tat cag tt #c gat ggg acg ccg gtg     1056 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 gtt aag gcg atg tgg agg gag gcg aag gag tg #t atc tat gtg gaa ccg     1104 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 gac agg caa ggt gag aag aaa ggt gtg ttc tg #g tac aac aat aag tta     1152 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 tga                   #                   #                   #           1155 <210> SEQ ID NO 18 <211> LENGTH: 384 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 18 Met Gly Ala Gly Gly Arg Met Gln Val Ser Pr #o Pro Ser Lys Lys Ser   1               5  #                 10  #                 15 Glu Thr Asp Thr Ile Lys Arg Val Pro Cys Gl #u Thr Pro Pro Phe Thr              20      #             25      #             30 Val Gly Glu Leu Lys Lys Ala Ile Pro Pro Hi #s Cys Phe Lys Arg Ser          35          #         40          #         45 Ile Pro Arg Ser Phe Ser Tyr Leu Ile Trp As #p Ile Ile Ile Ala Ser      50              #     55              #     60 Cys Phe Tyr Tyr Val Ala Thr Thr Tyr Phe Pr #o Leu Leu Pro His Pro  65                  # 70                  # 75                  # 80 Leu Ser Tyr Phe Ala Trp Pro Leu Tyr Trp Al #a Cys Gln Gly Cys Val                  85  #                 90  #                 95 Leu Thr Gly Val Trp Val Ile Ala His Glu Cy #s Gly His His Ala Phe             100       #           105       #           110 Ser Asp Tyr Gln Trp Leu Asp Asp Thr Val Gl #y Leu Ile Phe His Ser         115           #       120           #       125 Phe Leu Leu Val Pro Tyr Phe Ser Trp Lys Ty #r Ser His Arg Arg His     130               #   135               #   140 His Ser Asn Thr Gly Ser Leu Glu Arg Asp Gl #u Val Phe Val Pro Lys 145                 1 #50                 1 #55                 1 #60 Lys Lys Ser Asp Ile Lys Trp Tyr Gly Lys Ty #r Leu Asn Asn Pro Leu                 165   #               170   #               175 Gly Arg Thr Val Met Leu Thr Val Gln Phe Th #r Leu Gly Trp Pro Leu             180       #           185       #           190 Tyr Leu Ala Phe Asn Val Ser Gly Arg Pro Ty #r Asp Gly Gly Phe Ala         195           #       200           #       205 Cys His Phe His Pro Asn Ala Pro Ile Tyr As #n Asp Arg Glu Arg Leu     210               #   215               #   220 Gln Ile Tyr Ile Ser Asp Ala Gly Ile Leu Al #a Val Cys Tyr Gly Leu 225                 2 #30                 2 #35                 2 #40 Phe Arg Tyr Ala Ala Ala Gln Gly Val Ala Se #r Met Val Cys Phe Tyr                 245   #               250   #               255 Gly Val Pro Leu Leu Ile Val Asn Gly Phe Le #u Val Leu Ile Thr Tyr             260       #           265       #           270 Leu Gln His Thr His Pro Ser Leu Pro His Ty #r Asp Ser Ser Glu Trp         275           #       280           #       285 Asp Trp Leu Arg Gly Ala Leu Ala Thr Val As #p Arg Asp Tyr Glu Ile     290               #   295               #   300 Leu Asn Lys Val Phe His Asn Ile Thr Asp Th #r His Val Ala His His 305                 3 #10                 3 #15                 3 #20 Leu Phe Ser Thr Met Pro His Tyr His Ala Me #t Glu Ala Thr Lys Ala                 325   #               330   #               335 Ile Lys Pro Ile Leu Gly Glu Tyr Tyr Gln Ph #e Asp Gly Thr Pro Val             340       #           345       #           350 Val Lys Ala Met Trp Arg Glu Ala Lys Glu Cy #s Ile Tyr Val Glu Pro         355           #       360           #       365 Asp Arg Gln Gly Glu Lys Lys Gly Val Phe Tr #p Tyr Asn Asn Lys Leu     370               #   375               #   380 <210> SEQ ID NO 19 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: primer <400> SEQUENCE: 19 ggatatgatg atggtgaaag a            #                   #                   #21 <210> SEQ ID NO 20 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: primer <400> SEQUENCE: 20 tctttcacca tcatcatatc c            #                   #                   #21 <210> SEQ ID NO 21 <211> LENGTH: 21 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: primer <400> SEQUENCE: 21 gttatgaagc aaagaagaaa c            #                   #                   #21 <210> SEQ ID NO 22 <211> LENGTH: 26 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: primer <400> SEQUENCE: 22 gtttcttctt tgctttgctt cataac           #                   #              26 <210> SEQ ID NO 23 <211> LENGTH: 32 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: primer <400> SEQUENCE: 23 caucaucauc aucttcttcg tagggttcat cg        #                   #          32 <210> SEQ ID NO 24 <211> LENGTH: 33 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: primer <400> SEQUENCE: 24 cuacuacuac uatcatagaa gagaaaggtt cag        #                   #         33 <210> SEQ ID NO 25 <211> LENGTH: 32 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: primer <400> SEQUENCE: 25 caucaucauc aucatgggtg cacgtggaag aa        #                   #          32 <210> SEQ ID NO 26 <211> LENGTH: 33 <212> TYPE: DNA <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: primer <400> SEQUENCE: 26 cuacuacuac uatctttcac catcatcata tcc        #                   #         33 <210> SEQ ID NO 27 <211> LENGTH: 30 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 27 Ile Trp Val Ile Ala His Glu Cys Gly His Hi #s Ala Phe Ser Asp Tyr   1               5  #                 10  #                 15 Gln Trp Leu Asp Asp Thr Val Gly Leu Ile Ph #e His Ser Phe              20      #             25      #             30 <210> SEQ ID NO 28 <211> LENGTH: 30 <212> TYPE: PRT <213> ORGANISM: Glycine max <400> SEQUENCE: 28 Val Trp Val Ile Ala His Glu Cys Gly His Hi #s Ala Phe Ser Lys Tyr   1               5  #                 10  #                 15 Gln Trp Val Asp Asp Val Val Gly Leu Thr Le #u His Ser Thr              20      #             25      #             30 <210> SEQ ID NO 29 <211> LENGTH: 30 <212> TYPE: PRT <213> ORGANISM: Zea mays <400> SEQUENCE: 29 Val Trp Val Ile Ala His Glu Cys Gly His Hi #s Ala Phe Ser Asp Tyr   1               5  #                 10  #                 15 Ser Leu Leu Asp Asp Val Val Gly Leu Val Le #u His Ser Ser              20      #             25      #             30 <210> SEQ ID NO 30 <211> LENGTH: 29 <212> TYPE: PRT <213> ORGANISM: Ricinus communis <400> SEQUENCE: 30 Trp Val Met Ala His Asp Cys Gly His His Al #a Phe Ser Asp Tyr Gln   1               5  #                 10  #                 15 Leu Leu Asp Asp Val Val Gly Leu Ile Leu Hi #s Ser Cys              20      #             25 <210> SEQ ID NO 31 <211> LENGTH: 29 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 31 Leu Leu Val Pro Tyr Phe Ser Trp Lys Tyr Se #r His Arg Arg His His   1               5  #                 10  #                 15 Ser Asn Thr Gly Ser Leu Glu Arg Asp Glu Va #l Phe Val              20      #             25 <210> SEQ ID NO 32 <211> LENGTH: 29 <212> TYPE: PRT <213> ORGANISM: Glycine max <400> SEQUENCE: 32 Leu Leu Val Pro Tyr Phe Ser Trp Lys Ile Se #r His Arg Arg His His   1               5  #                 10  #                 15 Ser Asn Thr Gly Ser Leu Asp Arg Asp Glu Va #l Phe Val              20      #             25 <210> SEQ ID NO 33 <211> LENGTH: 29 <212> TYPE: PRT <213> ORGANISM: Zea mays <400> SEQUENCE: 33 Leu Met Val Pro Tyr Phe Ser Trp Lys Tyr Se #r His Arg Arg His His   1               5  #                 10  #                 15 Ser Asn Thr Gly Ser Leu Glu Arg Asp Glu Va #l Phe Val              20      #             25 <210> SEQ ID NO 34 <211> LENGTH: 29 <212> TYPE: PRT <213> ORGANISM: Ricinus communis <400> SEQUENCE: 34 Leu Leu Val Pro Tyr Phe Ser Trp Lys His Se #r His Arg Arg His His   1               5  #                 10  #                 15 Ser Asn Thr Gly Ser Leu Glu Arg Asp Glu Va #l Phe Val              20      #             25 <210> SEQ ID NO 35 <211> LENGTH: 36 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 35 Asp Arg Asp Tyr Gly Ile Leu Asn Lys Val Ph #e His Asn Ile Thr Asp   1               5  #                 10  #                 15 Thr His Val Ala His His Leu Phe Ser Thr Me #t Pro His Tyr Asn Ala              20      #             25      #             30 Met Glu Ala Thr          35 <210> SEQ ID NO 36 <211> LENGTH: 36 <212> TYPE: PRT <213> ORGANISM: Glycine max <400> SEQUENCE: 36 Asp Arg Asp Tyr Gly Ile Leu Asn Lys Val Ph #e His His Ile Thr Asp   1               5  #                 10  #                 15 Thr His Val Ala His His Leu Phe Ser Thr Me #t Pro His Tyr His Ala              20      #             25      #             30 Met Glu Ala Thr          35 <210> SEQ ID NO 37 <211> LENGTH: 36 <212> TYPE: PRT <213> ORGANISM: Zea mays <400> SEQUENCE: 37 Asp Arg Asp Tyr Gly Ile Leu Asn Arg Val Ph #e His Asn Ile Thr Asp   1               5  #                 10  #                 15 Thr His Val Ala His His Leu Phe Ser Thr Me #t Pro His Tyr His Ala              20      #             25      #             30 Met Glu Ala Thr          35 <210> SEQ ID NO 38 <211> LENGTH: 27 <212> TYPE: PRT <213> ORGANISM: Ricinus communis <400> SEQUENCE: 38 Asp Arg Asp Tyr Gly Ile Leu Asn Lys Val Ph #e His Asn Ile Thr Asp   1               5  #                 10  #                 15 Thr Gln Val Ala His His Leu Phe Thr Met Pr #o              20      #             25 <210> SEQ ID NO 39 <211> LENGTH: 16 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 39 Ile Lys Trp Tyr Gly Lys Tyr Leu Asn Asn Pr #o Leu Gly Arg Ile Met   1               5  #                 10  #                 15 <210> SEQ ID NO 40 <211> LENGTH: 16 <212> TYPE: PRT <213> ORGANISM: Glycine max <400> SEQUENCE: 40 Val Ala Trp Phe Ser Leu Tyr Leu Asn Asn Pr #o Leu Gly Arg Ala Val   1               5  #                 10  #                 15 <210> SEQ ID NO 41 <211> LENGTH: 16 <212> TYPE: PRT <213> ORGANISM: Zea mays <400> SEQUENCE: 41 Pro Trp Tyr Thr Pro Tyr Val Tyr Asn Asn Pr #o Val Gly Arg Val Val   1               5  #                 10  #                 15 <210> SEQ ID NO 42 <211> LENGTH: 16 <212> TYPE: PRT <213> ORGANISM: Ricinus communis <400> SEQUENCE: 42 Ile Arg Trp Tyr Ser Lys Tyr Leu Asn Asn Pr #o Pro Gly Arg Ile Met   1               5  #                 10  #                 15 <210> SEQ ID NO 43 <211> LENGTH: 22 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 43 Trp Ala Leu Phe Val Leu Gly His Asp Cys Gl #y His Gly Ser Phe Ser   1               5  #                 10  #                 15 Asn Asp Pro Lys Leu Asn              20 <210> SEQ ID NO 44 <211> LENGTH: 22 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 44 Trp Ala Leu Phe Val Leu Gly His Asp Cys Gl #y His Gly Ser Phe Ser   1               5  #                 10  #                 15 Asn Asp Pro Arg Leu Asn              20 <210> SEQ ID NO 45 <211> LENGTH: 22 <212> TYPE: PRT <213> ORGANISM: Glycine max <400> SEQUENCE: 45 Trp Ala Leu Phe Val Leu Gly His Asp Cys Gl #y His Gly Ser Phe Ser   1               5  #                 10  #                 15 Asn Asn Ser Lys Leu Asn              20 <210> SEQ ID NO 46 <211> LENGTH: 22 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 46 Trp Ala Ile Phe Val Leu Gly His Asp Cys Gl #y His Gly Ser Phe Ser   1               5  #                 10  #                 15 Asp Ile Pro Leu Leu Asn              20 <210> SEQ ID NO 47 <211> LENGTH: 10 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 47 Asp Arg Asp Tyr Gly Ile Leu Asn Lys Val   1               5  #                 10 <210> SEQ ID NO 48 <211> LENGTH: 22 <212> TYPE: PRT <213> ORGANISM: Glycine max <400> SEQUENCE: 48 Trp Ala Leu Phe Val Leu Gly His Asp Cys Gl #y His Gly Ser Phe Ser   1               5  #                 10  #                 15 Asp Ser Pro Pro Leu Asn              20 <210> SEQ ID NO 49 <211> LENGTH: 29 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 49 Ile Leu Val Pro Tyr His Gly Trp Arg Ile Se #r His Arg Thr His His   1               5  #                 10  #                 15 Gln Asn His Gly His Val Glu Asn Asp Glu Se #r Trp His              20      #             25 <210> SEQ ID NO 50 <211> LENGTH: 10 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 50 Asp Arg Asp Tyr Glu Ile Leu Asn Lys Val   1               5  #                 10 <210> SEQ ID NO 51 <211> LENGTH: 29 <212> TYPE: PRT <213> ORGANISM: Glycine max <400> SEQUENCE: 51 Ile Leu Val Pro Tyr His Gly Trp Arg Ile Se #r His Arg Thr His His   1               5  #                 10  #                 15 Gln His His Gly His Ala Glu Asn Asp Glu Se #r Trp His              20      #             25 <210> SEQ ID NO 52 <211> LENGTH: 29 <212> TYPE: PRT <213> ORGANISM: Arabidopsis thaliana <400> SEQUENCE: 52 Ile Leu Val Pro Tyr His Gly Trp Arg Ile Se #r His Arg Thr His His   1               5  #                 10  #                 15 Gln Asn His Gly His Val Glu Asn Asp Glu Se #r Trp Val              20      #             25 <210> SEQ ID NO 53 <211> LENGTH: 6 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 53 Lys Tyr His Asn Asn Pro   1               5 <210> SEQ ID NO 54 <211> LENGTH: 29 <212> TYPE: PRT <213> ORGANISM: Glycine max <400> SEQUENCE: 54 Ile Leu Val Pro Tyr His Gly Trp Arg Ile Se #r His Arg Thr His His   1               5  #                 10  #                 15 Gln Asn His Gly His Ile Glu Lys Asp Glu Se #r Trp Val              20      #             25 <210> SEQ ID NO 55 <211> LENGTH: 6 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 55 Gly His Asp Cys Ala His   1               5 <210> SEQ ID NO 56 <211> LENGTH: 6 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 56 Gly His Lys Cys Gly His   1               5 <210> SEQ ID NO 57 <211> LENGTH: 6 <212> TYPE: PRT <213> ORGANISM: Brassica napus <220> FEATURE: <221> NAME/KEY: VARIANT <223> OTHER INFORMATION: amino acid residues 94-99 # of Canola-Fad3 <400> SEQUENCE: 57 Gly His Asp Cys Gly His   1               5 <210> SEQ ID NO 58 <211> LENGTH: 5 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 58 His Lys Cys Gly His   1               5 <210> SEQ ID NO 59 <211> LENGTH: 6 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 59 Ala His Glu Cys Gly His   1               5 <210> SEQ ID NO 60 <211> LENGTH: 5 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 60 His Glu Cys Gly His   1               5 <210> SEQ ID NO 61 <211> LENGTH: 5 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 61 His Arg Arg His His   1               5 <210> SEQ ID NO 62 <211> LENGTH: 5 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 62 His Arg Thr His His   1               5 <210> SEQ ID NO 63 <211> LENGTH: 5 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 63 His Val Ala His His   1               5 <210> SEQ ID NO 64 <211> LENGTH: 6 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 64 Lys Tyr Leu Asn Asn Pro 1               5 <210> SEQ ID NO 65 <211> LENGTH: 29 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 65 Val Trp Val Ile Ala His Glu Cys Gly His Hi #s Ala Phe Ser Asp Tyr   1               5  #                 10  #                 15 Gln Trp Leu Asp Asp Thr Val Gly Leu Ile Ph #e His Ser              20      #             25 <210> SEQ ID NO 66 <211> LENGTH: 36 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 66 Asp Arg Asp Tyr Gly Ile Leu Asn Lys Val Ph #e His Asn Ile Thr Asp   1               5  #                 10  #                 15 Thr His Val Ala His His Leu Phe Ser Thr Me #t Pro His Tyr His Ala              20      #             25      #             30 Met Glu Ala Thr          35 <210> SEQ ID NO 67 <211> LENGTH: 16 <212> TYPE: PRT <213> ORGANISM: Brassica napus <400> SEQUENCE: 67 Ile Lys Trp Tyr Gly Lys Tyr Leu Asn Asn Pr #o Leu Gly Arg Thr Val   1               5  #                 10  #                 15 <210> SEQ ID NO 68 <211> LENGTH: 6 <212> TYPE: PRT <213> ORGANISM: Artificial Sequence <220> FEATURE: <223> OTHER INFORMATION: exemplary motif <400> SEQUENCE: 68 Ala His Lys Cys Gly His   1               5 

What is claimed is:
 1. A Brassica seed oil having a long chain monounsaturated fatty acid content of at least about 82% and an erucic acid content of at least about 15% based on total fatty acid composition.
 2. The oil of claim 1, said oil having an oleic acid content of at least about 37% based on total fatty acid composition.
 3. The oil of claim 1, said oil having an eicosenoic acid content of at least about 14% based on total fatty acid composition.
 4. The oil of claim 1, wherein said monounsaturated fatty acid content is from about 85% to about 90%.
 5. The oil of claim 4, said oil having an oleic acid content of at least about 42% based on total fatty acid composition.
 6. The oil of claim 5, wherein said oleic acid content is from about 47% to about 56%.
 7. The oil of claim 4, said oil having an erucic acid content of from about 17% to about 31% based on total fatty acid composition.
 8. The oil of claim 4, said oil having an eicosenoic acid content from about 15% to about 21% based on total fatty acid composition.
 9. The oil of claim 1, said oil having a saturated fatty acid content of less than about 7% based on total fatty acid composition.
 10. The oil of claim 1, said oil having a polyunsaturated fatty acid content of less than about 11% based on total fatty acid composition.
 11. The oil of claim 10, wherein said polyunsaturated fatty acid content is less than about 9%. 